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ABSTRACT 
 
Many azapolycyclic aromatic ring systems, whether they are naturally 
occurring or synthetically made, display important biological activities. One 
important class of naturally occurring azapolycyclic aromatic ring systems are 
the dibenzopyrrocoline alkaloids, which contain an indole ring fused to an 
isoquinoline moiety, where they share a common nitrogen. The basic skeleton 
of these alkaloids is the indolo[2,1-a]isoquinoline nucleus. Both the 
dibenzopyrrocoline alkaloids and the indolo[2,1-a]isoquinolines have been 
found to inhibit tubulin polymerization and thus possess antitumour and 
antileukemic activities. 
 
In our laboratories, a variety of indolo[2,1-a]isoquinolines, for example 5,12-
dimethyl-6-phenylindolo[2,1-a]isoquinoline, have been synthesized using the 
Suzuki-Miyaura cross coupling reaction and reaction conditions for the 
formation of aromatic rings (KOBut in DMF and a light source – developed in 
our laboratories) as key steps. In this dissertation we discuss the synthesis of 
(±)-5,6-dihydro-6-phenylindolo[2,1-a]isoquinolin-5-ol and ethyl indolo[2,1-
a]isoquinoline-6-carboxylate using these reaction conditions as our key steps. 
 
The syntheses commenced with the N-protection of isatin with a benzyl and 
an ethyl acetate group to afford 1-benzylindoline-2,3-dione and ethyl 2-(2,3-
dioxoindolin-1-yl)acetate respectively. The next step was the synthesis of the 
brominated compounds 1-benzyl-2-bromo-1H-indole and ethyl 2-(2-bromo-
1H-indol-1-yl)acetate by means of a functional group interconversion of the 
oxygen in the 3-position to two chlorine atoms, followed by 
hydrodehalogenation, using zinc in AcOH, and then bromination, using POBr3 
in CH2Cl2. Having obtained the brominated compounds we went on and 
coupled them with 2-formylphenylboronic acid using the Suzuki-Miyaura cross 
coupling reaction to obtain the coupled products 2-(1-benzyl-1H-indol-2-
yl)benzaldehyde and ethyl 2-(2-(2-formylphenyl)-1H-indol-1-yl)acetate in 92 
and 77% yield, respectively. Aromatisation of ethyl 2-(2-(2-formylphenyl)-1H-
indol-1-yl)acetate to ethyl indolo[2,1-a]isoquinoline-6-carboxylate occurred 
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smoothly in 2 minutes using 10 mol % KOBut in DMF at room temperature. 
Using the same reaction conditions on 2-(1-benzyl-1H-indol-2-
yl)benzaldehyde to form 6-phenylindolo-[2,1-a]isoquino-line resulted in (±)-
5,6-dihydro-6-phenylindolo[2,1-a]iso-quinolin-5-ol being obtained in 75% yield 
(7:3 ratio of anti:syn). An attempt to dehydrate this compound using p-TSA in 
CH2Cl2 in the presence of molecular sieves was not successful. Time 
constraints prevented any further attempts at dehydrating (±)-5,6-dihydro-6-
phenylindolo[2,1-a]iso-quinolin-5-ol. 
 
In conclusion, we managed to synthesize (±)-5,6-dihydro-6-phenylindolo[2,1-
a]isoquinolin-5-ol and ethyl indolo[2,1-a]isoquinoline-6-carboxylate using the 
Suzuki-Miyaura cross coupling reaction and specific reaction conditions, using 
the base KOtBu, for the formation of aromatic rings, both as key steps. 
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Chapter 1: Introduction 
 
Many naturally occurring, as well as synthetic, azapolycyclic aromatic ring 
systems display important biological activity and have found applications in 
the pharmaceutical and agricultural industries to name but a few. These 
compounds also known as alkaloids are mostly found in plants, but have also 
been isolated from mammals, salamanders, frogs and toads, mosses and 
fungi, marine organisms and arthropods. There are many different kinds of 
alkaloids and most have their biosynthetic origin from amino acids. The two 
largest groups of alkaloids are those made from tyrosine 1 and tryptophan 2. 
Those originating from tyrosine include the isoquinoline 3 or 
tetrahydroisoquinoline 4 nucleus. The alkaloids made from tryptophan are 
almost as varied as those made from tyrosine and include the indole nucleus 
5.1,2 
HO
COOH
HH2N
N
H
COOH
HH2N
N NH
N
H
1 2
3 4 5  
Figure 1 
 
Alkaloids, such as the dibenzopyrrocoline alkaloids, cryptaustoline 6 and 
cryptowoline 7, contain an indole ring fused to an isoquinoline moiety, where 
they share a common nitrogen atom. These alkaloids have been found to 
possess antitumour and antileukemic activities as well as tubulin 
polymerization inhibitory properties.3 Indolo[2,1-a]isoquinolines 8 and related 
compounds, such as the pyrrolo[2,1-a]isoquinolines 9, have been found to 
possess a similar skeleton and biological activities.4  
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Due to the broad application of polyfused heteroaromatic compounds 
(antimalarial, antileukemic, antitumour, antiviral, etc.), novel and more efficient 
methods for preparing them are of great interest to chemists and biologists.1,2   
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1.1. The Biological Importance of Indole and its Derivatives  
 
Indole is a benzopyrrole in which a pyrrole ring is fused to a benzene ring 
through the α- and β- positions of the pyrrole. It was first obtained by Adolf 
von Baeyer in 1866 by pyrolysis of oxindole 10 with zinc dust.5 The oxindole 
was obtained by the reduction of isatin 11 which was obtained by oxidizing the 
natural insoluble dark blue dye known as indigo 12, Scheme 1. Indigo is used 
in the textile industry to give jeans their blue colour by first reducing it to its 
soluble salt, leucoindigo 13. The jeans are then moistened with an aqueous 
solution of this salt and then exposed to air, which causes oxidation and thus 
precipitation of indigo in the fibres. Indole has also been isolated from certain 
flower oils such as jasmine and has been found to possess (when diluted) a 
strong pleasant odour. For this reason it has been used commercially in 
perfume formulations. Skatole, β-methylindole, 14 as well as indole 5 itself 
(when concentrated) have been found to be responsible for the foul odour of 
faeces.6 Today the principal commercial source of indole is by the extraction 
from coal tar.7 
 
N
H
O
H
N
O
N
H
OH
H
N
HO
N
H
O
O
N
H
O
N
H
Reduction
Oxidation
Oxidation
Reduction Pyrolysis
12 13
11 10  5 (R=H)
14 (R=Me)
R
 
Scheme 1 
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The indole alkaloids are a broad group of heterocyclic bases that contain the 
indole nucleus and whose structures vary in complexity. Most of these 
alkaloids are derived from tryptophan or the decarboxylated form of 
tryptophan, known as tryptamine 15. Trytophan or tryptamine undergo 
biological transformations giving rise to the various alkaloids. Some 
derivatives of tryptamine produce psychic effects and are classified in the 
group of drugs known as hallucinogens. Two well-known naturally occurring 
hallucinogens are psilocin 16, which is found in some species of Mexican 
mushrooms and lysergic acid 17, which is found in the ergot fungus.8 The 
diethylamide of lysergic acid is a synthetic drug better known as LSD 18 and 
is so powerful that it is capable of inducing symptoms similar to schizophrenia 
(Figure 3).6,8,9 
N
H
NH2
N
H
N(Me)2
15 16
OH
NH
NH
(Et)2NOC
H
Me
N
H
N
HOOC Me
17 18
H
 
Figure 3 
 
Other examples of indole-containing naturally occurring compounds, although 
not a comprehensive list, are: 
 
• Indole-3-acetic acid 19 also known as auxin which is a plant growth 
hormone (Figure 4).7 
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• Seratonin 20 which is a neurotransmitter in animals as well as a 
hormone that affects blood pressure.1  
N
H
COOH
N
H
HO
NH2
19 20  
Figure 4  
 
The fact that the indole alkaloids constitute such a broad group of compounds 
has resulted in the alkaloids being further divided into smaller groups of 
alkaloid families, such that compounds that are structurally similar are found 
together. A few different but important indole alkaloids will be discussed in the 
next few paragraphs.  
 
One of the most important alkaloids is strychnine 21 (Figure 5) which is not 
only the flagship compound of the family of Strychnos alkaloids, but is also 
one of the most complex alkaloid natural products (possessing seven rings 
and six stereogenic centers).10 It was first isolated by Pelletier and Caventou11 
in 1818 and was one of the first alkaloids obtained in its pure form. It was also 
found to be the active component of an arrow poison used in South-East Asia. 
In therapeutic doses it has a mild analeptic effect and in lethal doses it is a 
convulsant, blocking postsynaptic inhibition in the spinal cord by acting as an 
antagonist of glycine, an inhibitory neurotransmitter. Lethal doses also lead to 
uncoordinated tonic convulsions (convulsions in which muscle contraction is 
sustained). The lethal dose for an adult human is 100 - 300 mg.12 
 
N
O
N
O H
HH
A B
C
DE
F G
21  
Figure 5 
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Many syntheses of strychnine have been reported. Magnus’12,13 key step in 
the synthesis involved the transannular iminium ion cyclization of a nine-
membered ring for the stereoselective construction of rings C and E, Scheme 
2.  
N
H
N
H
C
E
CO2Me O
O
N
H
N
H
MeO2C O
O
H
N
H
N
H
MeO2C O
O
H
(i)
22 23
24  
Scheme 2: (i) Hg(OAc)2, CH3COOH. 
 
The shortest route (12-step synthesis) to date of (±)-strychnine was performed 
by Bodwell et al.14 Their synthesis involved a transannular inverse-electron-
demand Diels-Alder (IEDDA) reaction, which produced two stereogenic 
centers and constructed the C, E and F rings simultaneously, Scheme 3. 
 
N
N
CO2Me
N N
N
N CO2Me
(i)
C
E
F
25 26  
Scheme 3: (i) N,N-diethylaniline, ∆, 1 h. 
 
Ohshima and co-workers10 synthesized (-)-strychnine by using a zinc 
promoted tandem cyclisation to simultaneously construct the B and D rings, 
Scheme 4. 
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29  
Scheme 4: (i) Tf2O, i-Pr2NEt, then 2,2-bis(ethylthio)ethylamine, CH2Cl2, -78 ºC. (ii) Zn, MeOH-
aqueous NH4Cl. 
 
A more recent synthesis by Nakanishi and co-workers15 involved palladium 
catalysis to synthesize (-)-strychnine 21. The fact that palladium was used in 
the synthesis of all the rings indicates the importance of this metal as a 
catalyst in modern organic synthesis. Nakanishi then went on to synthesize 
tubifoline and dehydrotubifoline using a similar procedure.16 
 
The first enantioselective route, however was accomplished by Overman et. al 
and the key to their approach was the sequential cationic aza-Cope 
rearrangement/Mannich cyclization.17 Through various steps Overman 
synthesized the crucial compound azabicyclo[3.2.1]octane 30, Scheme 5. 
The amine was exposed to paraformaldehyde, which resulted in the aza-
Cope-Mannich cascade being triggered. First the amine was converted to the 
corresponding formaldiminium ion 31, which then underwent a cationic [3,3] 
sigmatropic rearrangement (aza-Cope) to give 32. This intermediate then 
underwent an intermolecular Mannich cyclization to obtain 33 in quantitative 
yield. The cyclized product then underwent a variety of conventional reactions 
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to yield strychnine in 25 steps with an overall yield of 3%. The biggest yield of 
strychnine obtained to date is 10% and was achieved by Rawal and Isawa.18  
 
NR2
HO
H
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OtBu
NR2
HO
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(i)
NR2
HO
N
OtBu
aza-Cope
NR2
Mannich
O
HH
N O
tBu
Various
 Steps
(-)-Strychnine
30 31 32
33
21
 
Scheme 5: (i) (CH2O)n, Na2SO4, CH3CN, Δ. 
 
Aspidospermine 34, a 2,3,3-trialkylindoline alkaloid, is found in South America 
in an evergreen tree known as Quebracho. Aspidospermine is used as a 
tonic, febrifuge and anti-asthmatic for the relief of various types of dyspnoea, 
especially in emphysema and in asthma.19 It has also been found to be a 
potential anti-HIV drug. There are many reported syntheses of this compound.  
A recent stereochemically controlled synthesis by Fukuda et al.20 involved the 
use of ring closing metathesis (RCM) on 35 to form the quaternary 
stereogenic center of 36 as shown in Scheme 6.  
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OTBDPS
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3435 36
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Scheme 6: (i) 10 mol% Grubbs I, CH2Cl2, 48h, rt (ii) Many steps. 
 
Vallesamidine 37 shown in Figure 6 is a 2,2,3-trialkylindoline alkaloid and is 
related to aspidospermine. Vallesamidine’s biological importance is unknown 
and its structure differs from aspidospermine in that C-19 is attached to C-2 
rather then C-12. The synthesis of aspidospermine type alkaloids involve 
quebranchamine-type intermediates, such as 38, and as a result, 
vallesamidine, containing the same stereochemistry at C-2, C-12 and C-19, it 
is regarded as a product of an “abnormal” cyclization.21,22 
 
N
N
Me
H
Et
N
N
Me
Et
3837
2
12
19
 
Figure 6 
 
Another important indole alkaloid is reserpine 39, a Rauvolfia alkaloid, which 
also falls under a family of alkaloids known as the indolo[2,3-a]quinolizine 
alkaloids. Although it is not a major drug now, it was one of the first 
compounds to show beneficial effects in the treatment of mental disorders and 
was also the forerunner of the medicinal tranquillisers.5,7 Other  indolo[2,3-
a]quinolizine alkaloids are sempervirine 40, serpentine 41, alstonine 42 and 
alloyohimbane 43 (Figure 7). These compounds exhibit a combination of 
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biological activity including cytostatic effects, anti-HIV, immunostimulant, 
sedative and antipsychotic activities.23  
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Figure 7 
 
A recent synthesis of alloyohimbane 43 by Padwa and co-workers24 involved 
the reaction of the thiocarboline 44 with the α-bromoacyl chloride 45 to 
generate the dipole thioisomünchnone 46, Scheme 7. This dipole readily 
underwent intramolecular dipolar cycloaddition to form the cycloadduct 47 in 
75% yield. Removal of the sulfur atom using Raney nickel followed by further 
reduction using LDA resulted in the (±)-alloyohimbane 43 being formed in 
42% yield.24, 25 Work in this area has also been done by Sainsbury. 
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Scheme 7: (i) (a) Ra-Ni, EtOH. (b) LAH. 
 
The only known β-carboline natural product to possess a benz[f]indolo[2,3-
a]quinolizine skeleton is tangutorine 48. This alkaloid was isolated in 1999 by 
Che and co-workers26 from the leaves of the Nitraria tangutorum. Tangutorine 
is related to the monoterpenoid indole alkaloids. Many of these alkaloids have 
been synthesized using the classic Pictet-Spengler cyclisation.27 However a 
novel approach to the synthesis of tangutorine was performed by Hsung and 
coworkers 28 that features an intramolecular aza-[3 + 3] formal cycloaddition 
and a Heck coupling for constructing the C2-C3 bond. The synthesis began 
with the protection and bromination of tryptamine 15 to form 49, Scheme 8. 
The Heck reaction of 49 with methyl acrylate 50, followed by reduction and 
hydrolysis yielded the amino alcohol 51. Condensation of the amino alcohol 
with 1,3-cyclohexanedione 52 and then oxidation with MnO2 and reaction with 
an amine led to the formation of the cycloaddition precursor 53. An 
intramolecular aza-[3 + 3] formal cycloaddition of 53 resulted in the pentacycle 
54 being formed. Various hydrogenation and reduction methods were then 
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required to finally synthesize tangutorine 48 in 19 steps with an overall yield of 
5.5%. 
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Scheme 8: (i) (a) phthalic anhydride, Et3N, toluene, ∆ (b) pyr-HBr-Br2, CH3Cl, THF, -10 °C (c) 
Boc2O, DMAP, CH2Cl2, rt (ii) (a) 5 mol % PPd(PPh3)4, Cy2NMe (1.1 Equiv.), toluene, 95 °C (b) 
Dibal-H, CH2Cl2, -78 °C, 1h (c) NaBH4, i-PrOH/H2O, rt then ∆, AcOH (iii) (a) Toluene, reflux 
(b) MnO2, CH2Cl2, rt (c) R2'NH, Na2SO4, EtOAc/toluene, 95 °C (iv) (a) Pd(OH)2, H2, EtOAc (b) 
LHMDS, THF, -78 °C, HMPA, Mander’s reagent (c) TFA, CH2Cl2, rt (d) NaBH4, AcOH, rt, 48h 
(e) LAH. 
 
Two structurally and biosynthetically related natural products are 
cryptotackieine 55 and cryptosanguinolentine 56. These two compounds were 
isolated from a shrub, indigenous to West Africa, which have been used in 
folk medicines as an antimalarial agent.29 Cryptosanguinolentine 56 was 
found to possess an angular indolo[3,2-c]quinoline ring system, while 
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cryptotackieine 55 was found to possess a linear indolo[3,2-b]quinoline ring 
system. N-methyl derivatives of these ring systems have been reported to 
display antimicrobial and cytotoxic activity.30 Fresneda et al.31 synthesized 
these two alkaloids from 1-methyl-3-(ο-azidophenyl)quinoline-2-one 57, a 
common intermediate. Selective indolization by an intramolecular aza-Wittig 
reaction of 57 afforded cryptotackieine 55, while nitrene insertion, to obtain 
58, followed by reduction afforded cryptosanguinolentine 56, Scheme 9.  
 
N O
Me
N3
N
Me
N
N
Me
N
57
55
5658
(i) (ii)
(iii)
N
Me
HN
O
 
Scheme 9: (i) o-xylene, 150 °C (ii) Red-Al, toluene, reflux (iii) MW, Me3P, nitrobenzene, 180 
°C. 
 
A much shorter synthesis of these two alkaloids was performed by Hajós et 
al.32 and employed the Suzuki-Miyaura cross coupling reaction. Cross 
coupling of 59 and 60 to afford the phenylquinoline 61 was followed by 
deprotection of the amino moiety and formation of the azide 62. Exposing the 
azide to high temperature resulted in ring closure to obtain 63. Methylation of 
63 resulted in cryptosanguinolentine 56, Scheme 10.  
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Scheme 10: (i) (a) H2SO4 (b) HNO2 (c) NaN3 (ii) ∆. 
 
In addition, cryptotackieine 55 was synthesized in 4 steps from 3-
bromoquinoline-N-oxide 64. The final ring closure of 65, after coupling and 
deprotection, involved the condensation of the amino moiety with the oxo 
function of the carbostyryl ring, Scheme 11.32 
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Scheme 11: (i) (a) TsCl/K2CO3 (b) MeI (c) 179 °C (ii) 174 °C. 
 
1.1.1. The Carbazoles 
 
Carbazoles also contain the indole nucleus and have a wide range of 
biological activities. In 1872 carbazole 66 (Figure 7) was isolated from coal 
tar by Graebe and Glazer.33 The first naturally occurring carbazole alkaloid to 
be reported was from Murraya koenigii and is known as murrayanine 67. 
Murrayanine was found to have antibiotic properties by Chakraborty et al.34 in 
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1965. Murraya koenigii is the richest known source of carbazole alkaloids and 
in India the leaves of this tree are used in curries.35  
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There are many different types of carbazoles depending on the type of groups 
and/or rings fused to them as well as the face that they are fused to. Naturally 
occurring as well as synthetic analogues of these carbazoles are important 
due to their biological activity.4 Pyrido-fused carbazoles such as elliptinium 68 
and ditercalcinium 69 for instance have been used for treating cancer (Figure 
8).36 Benzo[a]carbazoles such as 70 have been suggested as potential anti-
tumour agents,37 while the naphtho[a]carbazole 71 is a potential candidate for 
cancer treatment due to its DNA intercalative binding properties.25,38 
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Benzo[a]carbazoles, naphtho[a]carbazole and pyrido[2,3-a]carbazoles such 
as 72, 73 and 74 respectively have previously been synthesized in our 
laboratories and will be discussed in the next section (Figure 9). 
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Figure 9 
 
The method used employed the Suzuki-Miyaura cross coupling reaction of a 
substituted indole with a substituted aromatic molecule. The next step utilized 
a novel light- and base-assisted cyclization reaction to form the centrally 
positioned aromatic ring, i.e. the construction of the C5-C6 bond, Scheme 
12.4,39 These reaction conditions were shown to be very versatile in the 
synthesis of compounds containing the indole core. 
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Scheme 12: (i) 10 mol % Pd(PPh3)4. aq. Na2CO3, DME/EtOH (ii) KOBut, hv, DMF, 70-80 °C. 
 
Other biologically important indole containing compounds that have been 
synthesized in high yields using the Suzuki-Miyaura coupling as a key step 
are furostifoline 79, indolo[2,3-c]isoquinolines  80 and indazolo[3,2-a]-β-
carbolines 81 (Figure 10).32 
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1.2. Isoquinoline, Isoquinoline Derivatives and their Biological 
Importance 
 
Isoquinoline 3 (Figure 11) is an analogue of naphthalene 82 and was 
discovered in 1885 as an impurity in crude quinoline coal tar. The isoquinoline 
nucleus is found in several hundred alkaloids of highly varied structure. Just 
as with the indole alkaloids, these alkaloids are divided into families where 
they are related structurally and by their mode of formation in the biological 
system. Most of the alkaloids are derivatives of 1-benzyl-1,2,3,4-
tetrahydroquinoline 83 and arise in the natural organism through biological 
Mannich reactions.6 
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Figure 11 
 
The opium poppy plant is best known for its narcotic, opium, which is found in 
its seed capsule. Opium was used for many centuries for its ability to alleviate 
pain and to induce a euphoric state when eaten or smoked.40 The poppy 
capsule contains a complex mixture of alkaloids, the most important being the 
habit forming drug, morphine 84, which possess a modified 
tetrahydroisoquinoline unit (Figure 12). The diacetate of morphine is heroin 
85, which is more addictive and the monomethyl ether is codeine 86, which is 
less addictive and used in non-prescriptive medicine.6 
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The tetrahydroisoquinoline family has been studied thoroughly over the past 
twenty-five years, especially the anti-tumour antibiotics. There are fifty-five 
natural products in this family to date.41 The biological agents include 
cytotoxic agents that possess anti-tumour and anti-microbial activities. Apart 
from the six-membered ring containing a nitrogen, there are two core units in 
this family and they contain the quinone of 87 and the aromatic ring of 88 
(Figure 13).  
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The family is classified into three families of natural products, namely the: 
saframycin, naphthridinomycin/bioxalomycin and quinocarcin/tetrazomine 
families. The saframycins and naphthridinomycins/bioxalomycins possess a 
quinone core while the quinocarcins/tetrazomines possess an aromatic core. 
A recent review by Williams and Scott describes the biological activity and 
chemistry of these tetrahydroisoquinoline anti-tumour antibiotics.41 In this 
dissertation we will discuss the synthesis of these two core structures 
incorporated in saframycin A 89 and quinocarcin 90. 
 
Saframycin A 89 was isolated in 1997 by Aria et al.42 from Streptomyces 
lavendulae and had been found to display antitumour and antimicrobial 
activity. The first synthesis of (±)-saframycin A was reported by Fukuyama 
and co-workers in 1990.43 The synthesis made use of the classical aldol 
condensation reaction of 91 and 92 to obtain the carbinolamine 93, Scheme 
13. Lactam 94 was then obtained via a series of reductions, cyclisations and 
hydrogenations of 93. The protection of the lactam nitrogen, as the 
corresponding tert-butyl carbamate, activated the lactam for ring opening and 
followed by mild reduction afforded 95. Deprotection followed by a Pictet-
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Spengler reaction and Swern oxidation resulted in an aldehyde, which 
condensed with the amine to form an intermediate carbinolamine. The 
carbinolamine was trapped with NaCN to form the stable aminonitrile 96. 
Saframycin A was finally obtained after forming an amide, using pyruvyl 
chloride, followed by oxidation of the hydroquinones to quinones using DDQ.  
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Scheme 13: (i) (a) KOBut, t-BuOH (b) H2, Pd/C (c) TBSCl, Et3N, (d) CbzCl, Et3N, DMAP (e) 
92, KOBUt, tBuOH (f) DBU (ii) (a) NaBH4 (b) Formic acid (c) TBAF (d) H2, Ra-Ni (e) CH2O, 
NaBH3CN (iii) (a) Boc2O, DMAP (b) NaBH4 (iv) (a) TFA (b) BocNHCH2CHO (c) Swern 
oxidation, NaCN (v) (a) TFA (b) MeCOCOCl, NaHCO3 (c) DDQ.  
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An asymmetrical synthesis of (-)-saframycin A was performed by Martinez 
and Corey44 and made use of similar reaction conditions to that used by 
Fukuyama and Steven. The differentiating step in this synthesis was the set 
up of the stereochemistry of the tetrahydroisoquinoline. This step involved a 
rhodium-catalyzed asymmetric hydrogenation of the benzylic olefin 97, 
followed by deprotection and a Pictet-Spengler cyclization to afford the 
tetracycle 98, Scheme 14. 
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Scheme 14: (i) (a) Rh[(COD)-(R,R)-DiPAMP]+BF4-, H2 (b) BF3.OEt2, H2O (c) BF3.OEt2 (d) H2, 
10 %Pd/C. 
 
Quinocarcin 90 was isolated in 1983 from Streptomyces melanovinaceus by 
Tomita et al.45 It has moderate activity against Gram-(+) bacteria such as 
Staphylococcus aureus and Klebsiella pneumoniae, as well as potent 
antitumour activity against several tumour cell lines including: St-4 gastric 
carcinoma, MX-1 human mammary carcinoma and P388 leukemia. The 
synthesis of (-)-quinocarcin has been reported. Garner et al.46 published the 
first asymmetric synthesis and made use of chiral auxiliaries, an 
intermolecular 1,3-dipolar cycloaddition and an intramolecular Wittig 
cyclization that afforded the tetracycle 100, from 99, and eventually (-)-
quinocarcin 90. Unlike Garner et al., Tereshima47 started their synthesis using 
(S)-glutamic acid 101 as a basis for the stereochemistry required and finally 
synthesized (-)-quinocarcin using classical chemistry, Scheme 15.41 
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Scheme 15: (i) (a) MeSCH2S(O)Me, triton B, HCl, t-BuCOCl, Et3N, CO2CH(Ph)CH(Me)NLi (b) 
KHMDS, trisyl azide, HOAc, NaBH4 (c)H2, Pd/C, Maleic anhydride, Ac2O, NaOAc (d) 5N HCl, 
THF, MeN3 (e) hv (f) MOMCl, i-Pr2NEt, NBS, hv, PPH3, KOBut (ii) (a) H2, Ra-Ni, LiOH (b) 
Li/NH3, NaCN (c) TMSCl, NaI, AgNO3. 
 
The naphthylisoquinoline alkaloids have been found in two tropical plants, 
Ancistrocladaceae and Dioncophyllaceae.40 There is a rapidly growing interest 
in these alkaloids due to them possessing both stereogenic centers and chiral 
axes, as well as being one of the first polyketide-derived isoquinoline 
alkaloids. They also display antimalarial and antiprotozoal activities in vivo 
and in vitro.48 
 
Ancistroealaine A 102, a naphthylisoquinoline alkaloid, had recently been 
found to be highly active against Leishmania donovani, the pathogen of 
visceral leishmaniasis (Kala Azar).49  In a publication by Bringmann and co-
workers the synthesis of 102 and ancistrotanzanine B 103, using Suzuki-
Miyaura coupling reactions, was reported. The naphthalene 104 and the 
heterocycle 105 were coupled using Pd2(dba)3 as a catalyst to afford the 
desired alkaloids in a 25:75 diastereomeric ratio (102:103), Scheme 16. The 
remarkable fact in this synthesis was that Suzuki-Miyaura coupling managed 
to work in the presence of a free imino function. The reason for this is still 
being investigated.48 
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Scheme 16: (i) Toluene/H2O, NaHCO3, 5 mol % Pd(dba)3. 
 
1.2.1. The Phenanthridines 
 
Phenanthridines and their benzo analogues are fused isoquinolines, found 
throughout the plant kingdom, possessing a broad range of biological 
properties.50 Many phenanthridines exhibit antileukemic and antiviral 
activities. They have been found in the metabolites of plant families and their 
ring system is present in many synthetic dyestuffs.50,51 Various methods have 
been employed in the synthesis of the phenanthridines including aromatic and 
heteroaromatic annelation51, Bischler-Napieralski cyclization52, and palladium-
assisted coupling50,53. 
 
Patra et al.51 synthesized a variety of substituted phenanthridines, 
benzo[j]phenanthridines and naphtha[2,1-j]phenanthridines, using aromatic 
and heteroaromatic annelation methodology, Scheme 17. They showed that 
by reacting N-benzenesulfonyl-3-[bis(methylthio)methylene]-1,2,3,4-
tetrahydroquinoline-4-one 106 with a substituted alkene-, benzyl- or naphthyl-
Grignard 107, in ether, resulted in the formation of a carbinolacetal 108. This 
carbinolacetal would undergo cyclisation in the presence of BF3.Et2O to form 
dihydrophenanthridine, benzo[j]dihydrophenanthridine and naphtho[2,1-
j]dihydrophenanthridines respectively 109. These compounds were 
aromatized by treatment with NaOH in toluene at reflux in the presence of a 
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phase transfer catalyst to afford 110. Finally dethiomethylation was performed 
using Raney nickel to afford substituted phenanthridines 111. 
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Scheme 17: (i) Et2O, THF (ii) BF3.Et2O/C6H6 (iii) Bu4N+ -OH, toluene, ∆ (iv) Ra-Ni. 
 
Benzo[c]phenanthridines such as nitidine 112 and fagaronine 113, an 8,9-
disubstituted planar benzophenanthridinium salt, possess anti-leukemic 
activity.52 Fagaronine’s anti-tumour activity has been traced to the inhibition of 
DNA topoisomerase and has been attributed to the conformationally rigid 
embedded 2-phenylnaphthalene subunit.52,54 Other benzo[c]phenanthridine 
alkaloids of importance are chlerythrine 114, which inhibits protein kinase C 
and isofagaridine 115, which inhibits DNA topoisomerase I.53 
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Figure 14 
 
Treus et al.,52 using a Bischler-Napieralski cyclization, have recently 
synthesized fagaronine 113, nitidine 112 and chelerythrine 114. Their 
synthesis involved reacting 116 with Tf2O and DMAP in chloroform to yield the 
Bischler-Napieralski cyclized product 117, Scheme 17. Oxidation with TTN 
(thallium trinitrate), followed by reaction with aqueous HCl, resulted in the 
benzo[c]phenanthridinone 118. Reduction of 118 with LAH, followed by 
oxidation with DDQ and O-dealkylation with sulfuric acid afforded the naturally 
occurring benzo[c]phenanthridines. 
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Scheme 18: (i) Tf2O, DMAP, CH2Cl2, 0 °C, 1.5h (ii) (a) Tl(NO3)3.3H2O, MeOH, rt, 5 min (b) aq. 
HCl, rt, 40-60 min (iii) (a) LiAlH4, THF, 3h (b) DDQ, C6H6, 2h (c) H2SO4, AcOH, 2.5h. 
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Modern day approaches in synthesizing alkaloids, as seen previously in this 
dissertation, often make use of palladium as a catalyst. Chelerythrine 114 and 
nitidine 112 have been synthesized by Harayama53,54 and Geen50 under 
slightly different conditions. Harayama and co-workers first treated 119 and 
120 with oxyalyl chloride in the presence of NEt3 to afford the amide 121, 
Scheme 19.1. Cyclisation of 121 to 122, using Pd(OAc)2, PPh3 and Ag2CO3 in 
DMF, followed by reduction (LAH) and then oxidation (DDQ) resulted in the 
desired alkaloids. Geen synthesized the bromine 123 and boronic acid 124 
compounds, which they coupled using Suzuki-Miyaura coupling methodology, 
Scheme 19.2. The aldehyde and the free amine then reacted in the presence 
of the base to form the desired aromatic product. 
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Scheme 19.1: (i) NEt3 (ii) MeI, 20 mol % Pd(OAc)2, PPH3, Ag2CO3, DMF (iii) LiAlH4 then 
DDQ. 
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Scheme 19.2: (i) Pd(OAc)2, PPh3, DME, aq. Na2CO3, 21 h. 
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1.3. Dibenzopyrrocoline Alkaloids, Indolo[2,1-a]isoquinolines and 
Related Analogues 
 
Thus far we have briefly discussed the biological importance of the indole and 
isoquinoline nuclei in Nature as well as in the pharmaceutical industry. We will 
now discuss the importance of the dibenzopyrrocoline alkaloids, the 
indolo[2,1-a]isoquinoline 8 derivatives (Figure 15) and related analogues as 
this is the main topic of this dissertation. These compounds contain an 
isoquinoline nucleus fused to an indole moiety where they share a common 
nitrogen. The dibenzopyrrocoline alkaloids form part of the isoquinoline 
alkaloids and tetrahydroisoquinoline family, and possess a 5,6,12,12a-
tetrahydro-indolo[2,1-a]isoquinoline skeleton 125. 
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Figure 15 
 
In 1932 Robinson and Sugasawa prepared dehydrolaudanosoline 126, a rare 
dibenzopyrrocoline-type alkaloid, from the oxidative cyclization of 
laudanosoline 127, Scheme 20.55 Since the reaction went very smoothly they 
predicted that these type of alkaloids would one day be found in Nature. Two 
decades later, in 1952, (-)-cryptaustoline 6 and (-)-cryptowoline 7 were 
isolated from Cryptocaria bowiei, a plant indigenous to Queensland, Australia, 
as their water soluble iodide salts.56 Although the biological action of these 
two alkaloids are uncertain they have been found to cause neurological 
paralysis by acting as a respiratory poison.57,58 
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Scheme 20: (i) o-Chloranil. 
 
Many syntheses of (-)-cryptaustoline 6 starting from a substituted 1-
benzylisoquinoline have been reported. The synthesis of (-)-cryptaustoline by 
Brossi et al.59, starting from (+)-laudanosoline 128, will now be discussed and 
is shown in Scheme 21. Brossi and co-workers performed an oxidative 
cyclisation using horse radish peroxidase-hydogen peroxide, which resulted in 
laudanosoline being oxidized to the intermediate Michael acceptor 129. The 
cyclised product 130 then formed by way of a Michael addition. Methylation of 
the phenol substituents resulted in (-)-cryptaustoline 6 being obtained.60,61 
 
The inversion of stereochemistry of trans-laudanosoline 128 to cis- 
cryptaustoline 6, led Meyer et. al58,61 to perform some kinetic studies on this 
synthesis. These studies showed that if the stereochemistry was retained 
after the Michael addition, the trans-fused product 131 obtained would be less 
stable then the cis-fused end product 130 due to ring strain. It was suggested 
that the trans-fused product 131 would undergo a second phenolic oxidation 
to the quinone methide 132. The newly formed stereocentre would now 
anchor the absolute stereochemistry and allow reprotonation to obtain the 
more stable cis-fused product 130. 
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Scheme 21: (i) HRP-H2O2, MeI. 
 
An asymmetric synthesis of (±)-O-methylcryptaustoline iodide 133, starting 
from the keto acid 134, was performed by Elliot, Scheme 22.62 The keto acid 
was nitrated, reduced and then cyclized to the nitro lactone 135. Reduction of 
the nitro group with catalytic hydrogenation using iron dust in warm acetic acid 
afforded the amino lactone 136. Conversion of 136 to the lactam 137 (TFA in 
CH2Cl2) followed by reduction with BH3·THF complex and treatment with 
methyl iodide gave (±)-O-methylcryptaustoline iodide 133.  
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Scheme 22: (i) AcOH, HNO3, 0 °C then EtOH, NaBH4 (ii) Fe dust, AcOH, 60 °C, 1.5 h (iii) 
CH2Cl2-TFA, 18h then toluene, MgSO4, reflux, 24h (iv) BH3-THF, 20 h. 
 
A third dibenzopyrrocoline alkaloid recently isolated from Manglietia chingii, a 
tall indigenous tree to the Guanxi and Guangdong provinces of China, was (-)- 
mangochinine 138 (Figure 16).57 The bark of this tree has been used in 
Southern and South-Western China for the treatment of ulcers, as a muscle 
relaxant and for anti-bacterial therapy. The dibenzopyrrocoline, (-)-
mangochinine, is believed to play a role in the biological activity of this bark. 
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The indolo[2,1-a]isoquinoline derivatives contain a unique tetracyclic structure 
characteristic of the dibenzopyrrocoline alkaloids. Several methods for the 
construction of this skeleton have been reported. One well known synthesis 
involves the oxidative coupling of 1-benzylisoquinoline 83.63 Other syntheses 
include: (a) the cyclization of substituted 1-(2’-bromobenzyl)-3,4-
dihydroisoquinolines 139 by heating at reflux in DMF in the presence of 
K2CO3 to afford 140, Scheme 23.64  
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Scheme 23: (i) K2CO3, DMF, reflux. 
 
(b) the cycloannulation of 141 with p-benzoquinone 142 to afford 143 in a 
Nenitzescu-type reaction, Scheme 24.65  
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Scheme 24: (i) CH3NO2, rt, 48 h. 
and (c) the conversion of a nitro keto acid 144 to benzopyrrocoline derivative 
145, which easily transformed into an indolo[2,1-a]isoquinoline 146 under 
reflux with zinc, Scheme 25.66 
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Scheme 25: (i) MeOH, H2SO4 then H2, Pd/C, MeOH/i-PrOH then p-TsOH, CH2Cl2 (ii) Zn, HCl, 
AcOH/H2O. 
 
Anti-estrogens such as tamoxifen 147, Figure 17, have been used in the 
treatment of breast cancer both in the treatment of primary breast cancer and 
in the advanced disease. Approximately 40% of patients with estrogen 
receptor positive breast tumours however, do not show a clinical response to 
tamoxifen treatment.67 The fact that a large fraction of steroid hormone 
receptor positive tumours do not respond to or have become resistant to anti-
hormonal treatment means that the development of new, improved drugs for 
the treatment of hormone-dependent carcinomas, such as mammary and 
prostatic cancer, are needed.  
Et
147  
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Figure 17 
Early studies have shown that the indolo[2,1-a]isoquinoline structure is 
suitable for binding to estrogen receptors. This structure is similar to non-
steroidal and steroidal estrogens and might be capable of intercalating into 
DNA. Recent studies have been done on acetoxy-substituted 5,6-
dihydroindolo[2,1-a]isoquinolines 148 (Figure 18). These studies included 
their binding affinity to steroid hormone receptors, endocrine activity and 
cytostatic effect on hormone-independent MDA-MB 231 and hormone-
dependent MCK-7 mammary tumour cells. It was found that compounds with 
acetoxy groups at the 3 and 10 positions, bound to steroid hormone receptors 
the best and at a concentration of 10-5M a strong cytostatic effect was 
observed on both cell lines.68 
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Another recent study, of a variety of hydroxy-substituted indolo[2,1-
a]isoquinolines, showed that these compounds inhibited the growth of human 
mammary carcinoma cells.3 It was suggested that the inhibition could be due 
to the compounds interfering with the tubulin system, which is involved in cell 
division. Further investigation revealed that the hydroxy-substituted indolo[2,1-
a]isoquinolines were indeed binding to the colchicine-binding site and thereby 
inhibiting tubulin poymerization. The hydroxy-substituted indolo[2,1-
a]isoquinoline that showed the highest activity was 6-butyl-12-formyl-5,6-
hydro-3,9-dihydroxy indolo[2,1-a]isoquinoline 149 (Figure 19). 
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Figure 19 
Two groups of compounds related to the dibenzopyrrocoline alkaloids and the 
indolo[2,1-a]isoquinolines are the pyrrolophenanthridines 150 and the 
pyrrolo[2,1-a]isoquinolines 151 (Figure 20). The pyrrolophenanthridines 150 
also possess an isoquinoline nucleus fused to an indole moiety where they 
share a common nitrogen atom; however C10 is fused to C3 instead of C8. 
The pyrrolo[2,1-a]isoquinolines 151 on the other hand have an isoquinoline 
nucleus fused to a pyrrole moiety instead of an indole unit. 
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Figure 20 
 
Pyrrolophenanthridines have been isolated from the plants of the family 
Amaryllidaceae.69 These alkaloids have been found to exhibit antitumour, 
antiviral and insect antifeeding activity. Pyrrolophenanthridones such as 
hippadine 152, reversibly inhibit fertility in male rats.70,71  
 
Harayama et al.64 and Shao et al.69 recently synthesized a variety of 
pyrrolophenanthridines, including (±)-γ-lycorane 153 from 154, using Pd-
mediated intramolecular biaryl coupling followed by selective hydrogenation of 
155, as shown in Scheme 26. 
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Scheme 26: (i) Pd(OAc)2, P(o-tol)3, K2CO3, DMF. 
 
Oxaoassoanine 156, a pyrrolophenanthridone, was synthesized by Meyers 
and Hutchings70 by coupling an aryl Grignard (from 1-benzyl-7-bromoindole 
157) with an aryl oxazoline 158. The biaryl compound 159 was partially 
hydrolysed, trans-esterified and the benzyl group removed by hydrogenation 
to afford a free amine 160 that spontaneously underwent acylation, with the 
adjacent carbomethoxyl, to the pyrrolophenanthridone 156, Scheme 27. 
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Scheme 27: (i) Mg, THF, BrF2CCF2Br, rt then 158, ∆, 12-15 h (ii) 10 % H2SO4/EtOH, ∆, 24 h 
then NaOMe/MeOH, ∆, 3 h (iii) Pd/C, AcOH, MeOH, H2. 
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Some of the pyrrolo[2,1-a]isoquinolines exhibit antineoplastic and 
antidepressant activities. The pyrrolo[2,1-a]isoquinoline bis(carbamate) 161 
has recently been shown to possess antileukemic activity, in vivo, against 
P388 leukemia, Figure 21.72 A recent study by Maryanoff et al.73 showed that 
a variety of pyrrolo[2,1-a]isoquinolines, including 6α-phenylpyrrolo[2,1-
a]isoquinoline 162, inhibited serotonin (5-HT), norepinephrine and dopamine 
uptake in the central nervous system. As a result, these compounds can be 
used in the treatment of depression, obesity, obsessive-compulsive disorders 
and alcohol abuse. 
N
Ph
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Figure 21 
 
A synthesis of 6α-phenylpyrrolo[2,1-a]isoquinoline, using chiral formamidines, 
was accomplished by Meyers and Guiles.74 The chiral formamidine formed 
163 was first exposed to alkylating conditions (s-BuLi, 1-chloro-3-
iodopropane, -100 ºC) and then to hydrazine in ethanol, in order to produce 
the secondary amine 164. This amine spontaneously cyclized to form 162 and 
165 in a 13:1 ratio in a greater than 80% yield as shown in Scheme 28. 
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Scheme 28: (i) R'Li, Cl(CH2)3I then NH2NH2, H3O+. 
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Chinese folk medicine for the treatment of colds, stomach aches and 
rheumatism often makes use the extracts of the plant Carduus crispus.75 
These extracts contain the pyrrolo[2,1-a]isoquinoline alkaloid, crispine A 166, 
which displays antitumour activity. Knölker and Agarwal.76 synthesized this 
natural product by means of a silver(I)-promoted oxidative cyclization of a 
trimethylsilyl alkyne 167 to 168, followed by chemoselective hydrogenation as 
depicted in Scheme 29. 
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Scheme 29: (i) AgOAc, CH2Cl2, rt, 14 h (ii) 5 mol % Rh/C, H2, AcOH/MeOH, rt, 192 h. 
 
In conclusion, it can seen that indolo[2,1-a]isoquinolines and related 
analogues possess a variety of biological activities. Although many methods 
have been employed in their synthesis, it is always important to improve and 
develop new, shorter, higher yielding methods of synthesizing these 
compounds. Various indolo[2,1-a]isoquinoline derivatives have been 
synthesized previously in our laboratories,77 one of which will be discussed in 
the next section. 
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1.4. Previous Syntheses of Indolo[2,1-a]isoquinolines 
 
As mentioned before, many polyfused heteroaromatics are of interest due to 
their potential DNA intercalating and reverse transcriptase inhibiting abilities. 
Due to the importance of indolo[2,1-a]isoquinolines 8, many methods have 
been employed in the formation of the indolo[2,1-a]isoquinoline nucleus. The 
most common disconnection is between the isoquinoline nitrogen and the 
benzene ring, which forms part of the indole nucleus. Scheme 30 shows the 
retrosynthesis from the indoloisoquinoline derivative 169 to the isoquinoline 
derivative 170. Radical58,67 (a), base53 (b) and benzyne50 mediated (c) ring 
closure methods have been used in the construction of this bond.  
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Scheme 30: (a) X=Br, AIBN, Bu3SnH
68,78; (b) X=Br, K2CO3, DMF, reflux, 3d
63; (c) X=Cl, 
nBuLi, THF, -100°C61. 
 
The synthesis of indolo[2,1-a]isoquinolines are of great interest to our 
research group and makes use of a novel disconnection at C-5 and C-6, 
shown in Scheme 30. 
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In our laboratories de Koning and co-workers have used the Suzuki-Miyaura 
coupling reaction32, as well as well-developed reaction conditions discovered 
for the formation of aromatic rings39,79,77 (KOBut, hv, DMF, 80 °C) to 
synthesise the indolo[2,1-a]isoquinoline derivative 172, shown in Scheme 31. 
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Scheme 31: (i) NBS, CCl4, 3 h then aq. NaOH, BnBr (ii) 175, 10 mol % Pd(PPh3)4, aq. 
Na2CO3, DME (iii) KOBut, DMF, 80 °C (iv) 15 mol % TsOH, CH2Cl2, rt, 24 h. 
 
The first step of the reaction was to synthesise the 1-benzyl-2-bromo-skatole 
174 using published chemistry.80 Suzuki-Miyaura coupling of 174 with the 
boronic acid 175 resulted in the coupled product 176 being obtained in 64% 
yield. Exposure of 176 to the novel reaction conditions for forming aromatic 
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rings (KOBut in DMF and a light source) resulted in the formation of 
diastereoisomers 177 and 178 in a 1:3 ratio. The major diastereoisomer, 
obtained in 74% yield, was found to be 178 by 1H NOE NMR spectroscopy. 
The major diastereoisomer was exposed to 15 mol% TsOH to afford the 
indolo[2,1-a]isoquinoline derivative 172 in 79% yield.77 
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1.5. Aims  
 
The simple reaction conditions and high yields of the synthesis described in 
Scheme 31, forms the basis of this MSc project. Using these conditions we 
will attempt to synthesize the indolo[2,1-a]isoquinoline skeleton of the 
dibenzopyrrocoline alkaloids 6 and 7.  
 
The first part of the project will involve the synthesis of the phenyl substituted 
indolo[2,1-a]isoquinoline 179, as an extension to our previous work. 
Examination of the disconnection in Scheme 32 shows that the target 179 
can be disconnected to the 1-(tert-butoxycarbonyl)-1H-indol-2-yl-2-boronic 
acid 180 and 2-bromobenzaldehyde 181. In Chapter 2 the initial attempt to 
synthesize 179 starting from indole, the problems which occurred and the 
alternative employed, using isatin 182, will be discussed.  
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Scheme 32 
 
Once 179 is successfully synthesized we will go on to synthesize ethyl 
indolo[2,1-a]isoquinoline-6-carboxylate 183 using the same reaction 
conditions. Starting from isatin 182 we will first synthesize ethyl 2-(2-bromo-
1H-indol-1-yl)acetate 184, which can then be coupled with 2-
formylphenylboronic acid 185 to form ethyl 2-(2-(2-formylphenyl)-1H-indol-1-
yl)acetate 186. Aromatisation of 186 using KOBut in DMF at 80 °C in the 
presence of a light source, would afford 183. The theory behind this is that 
the ester group would be easier to remove by decarboxylation than the 
phenyl substituent and would thus result in the formation of the 
indolo[2,1-a]isoquinoline skeleton 8 via the acid 187, Scheme 33. 
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Scheme 33: (i) (a) CaH2, CH3CH2CO2CH2Br, DMF, 45 °C, 24h (b) PCl5, C6H6, rt, 24h (c) Zn 
powder (14 equiv.), AcOH, 5 min (d) POBr3, CH2Cl2, rt (ii) Pd(PPh3)4 (10 mol %), 185, aq. 
Na2CO3, DME, reflux (iii) KOBut, DMF, rt (iv) ∆, H+ (v) DCC, DMAP, Bu3SnH. 
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Chapter 2: Results and Discussion 
 
2.1. The Attempted Synthesis of 6-Phenylindolo[2,1-a]isoquino-
line 179 and 5-Methyl-6-phenylindolo[2,1-a]isoquinoline 188 
 
The first two steps in the synthesis of compounds 179 and 188, Figure 22, 
were identical to that in the literature and were performed using well-
documented methodology81,82, Scheme 34. 
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Figure 22 
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Scheme 34: (i) Boc2O (1.3 equiv.), DMAP (5 mol %), THF, rt, 24 h. (ii) TMP (1.3 equiv.), n-
BuLi (1.2 equiv.), B(OMe)3 (5 equiv.), THF. 
 
The first step involved the protection of the indole nitrogen with a Boc group to 
afford tert-butyl 1H-indole-1-carboxylate 189, as we wanted to use the Boc 
group as a director for n-BuLi deprotonation and thus introduce substituents at 
the 2-position of the indole nucleus. We commenced the synthesis by 
dissolving indole in THF and then adding Boc2O (1.3 equiv.) and DMAP (5 
mol %). The reaction mixture was stirred at rt for 24 h, under nitrogen, before 
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it was extracted and then purified, by distillation, to afford the desired product, 
189, as a clear oil in 79% yield. The 1H NMR spectrum showed a singlet at 
1.66 ppm, integrating for 9 protons, which is characteristic of the three methyl 
groups attached to the quaternary carbon of the Boc group. The singlet at 
7.89 ppm corresponding to the N-H proton had also disappeared, from the 
starting material, indicating that 189 had been formed. 
 
The next step was to synthesize 1-(tert-butoxycarbonyl)-1H-indolyl-2-boronic 
acid, 190, by using the Boc substituent as a director to lithiate the 2-position of 
the indole, so that the boronic acid of 190 would be placed solely at the 2-
positon.   
 
The synthesis of 190 commenced by dissolving TMP (1.3 equiv. relative to 
189) in THF in a 2-neck, round bottom flask, equipped with a dropping funnel 
that contained a solution of tert-butyl 1H-indole-1-carboxylate in THF. The 
reaction temperature was lowered to −78 °C and n-BuLi (1.2 equiv.) was 
added dropwise using a syringe over 5 mins. After increasing the temperature 
to rt for 30 mins and then lowering it to −78 °C, the solution in the dropping 
funnel was added. The reaction was then stirred for 1.5 h at this temperature, 
B(OMe)3 (5 equiv.) was added and the solution was stirred for a further 0.5 h 
at −78 °C. The reaction mixture was warmed up to r.t, acidified with a 1M 
aqueous HCl solution and then the organic material was extracted into ether. 
The organic solvent was removed to afford a 0.1 M solution, cold hexane was 
added and the boronic acid, 190, precipitated out as a white solid in 65% 
yield. The 1H NMR spectrum showed that the doublets at 6.55 ppm and 7.55 
ppm, corresponding to protons 2-H and 3-H, had disappeared and that two 
singlets appeared at 7.50 ppm (corresponding to the 3-H proton) and 7.54 
ppm (corresponding to 2×OH protons), indicating that the boronic acid, 190, 
had been formed.  
 
One of the key steps, in our synthesis of indolo[2,1-a]isoquinolines, used 
Suzuki-Miyaura coupling methodology.83 This coupling involved a palladium 
catalyst, which aided in the cross coupling of a halogen or triflate and a boron-
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containing compound, which was a boronic acid. The methodology also 
makes use of a base which is believed to form the borate of the the boronic 
acid. Scheme 35 shows the believed basic catalytic cycle of the palladium 
catalyst. First the halogen or triflate partner undergoes reaction with the Pd(0) 
phosphine complex by means of an oxidative addition to form a Pd(II) 
species. The R1 nucleophilic species, which is the boron-containing partner in 
this case, is transferred from the metal to the Pd(II) complex in a step known 
as transmetallation. The new Pd(II) complex, having the two organic ligands 
bound, will then undergo reductive elimination to yield the coupled product 
and the Pd(0) catalyst, which is ready for another catalytic cycle.84 
  
tert-Butyl 2-(2-formylphenyl)-1H-indole-1-carboxylate, 191, and tert-butyl 2-(2-
acetylphenyl)-1H-indole-1-carboxylate, 192, were synthesized using this key 
palladium mediated step. 
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Scheme 35: Catalytic cycle of Pd(0) species in Suzuki-Miyaura coupling. 
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In the synthesis of, 191, 2-bromobenzaldehyde, 181, 1-(tert-butoxycarbonyl)-
1H-indol-2-yl-2-boronic acid, 190, (1.5 equiv.) and DME were combined and 
degassed in a dropping funnel before being added to a round bottom flask, 
containing Pd(PPh3)4 (10 mol %) (Scheme 36). The base, a 2M Na2CO3 
solution (5 equiv.) was degassed and added to the reaction mixture. The 
resulting mixture was heated under reflux for 72 h to obtain tert-butyl 2-(2-
formylphenyl)-1H-indole-1-carboxylate 191, after purification by silica gel 
column chromatography, as a white solid in 85% yield. The two singlets at 
7.50 and 7.54 ppm in the 1H NMR spectrum of 191 had disappeared and two 
new singlets at 6.60 ppm (corresponding to the 3-H proton) and 10.01 ppm 
(corresponding to the aldehyde proton) had appeared. The triplet at 7.25 ppm 
and the multiplet at 7.35 ppm, integrating for two protons, were now two 
multiplets at 7.26-7.47 ppm and 7.51-7.66 ppm and integrated for six protons. 
The 13C NMR spectrum showed a peak at 191.6 ppm, which is characteristic 
of the carbon of an aldehyde carbonyl. The spectrum also showed the 
presence of seven aromatic carbons bearing no hydrogen atoms, nine 
aromatic carbons bearing one hydrogen atom and a methyl peak at 27.5 ppm. 
The IR spectrum showed a carbonyl peak at 1698 cm-1 and an ArC=C peak at 
1600 cm-1. The high-resolution mass spectrum showed a molecular ion peak 
at m/z 321.1323 (C20H19NO3 requires 321.1365), indicating that 191 had been 
formed. In addition, the melting point of 191 was found to be 127-128 °C. 
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Scheme 36: (i) Pd(PPh3)4 (10 mol %), 2M Na2CO3 (5 equiv.), DME, reflux, 3 days. 
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In the synthesis of tert-butyl 2-(2-acetylphenyl)-1H-indole-1-carboxylate, 192, 
the same procedure as above was carried out except that 1-(2-
bromophenyl)ethanone 175 was cross-coupled to 190 instead of 2-
bromobenzaldehyde 181. After purification, 192 was obtained as an orange-
pink solid in 63% yield. The two singlet peaks at 7.50 and 7.54 ppm on the 1H 
NMR spectrum had disappeared, as mentioned above; however the two new 
singlets formed were at 2.33 ppm (corresponding to the CH3C=O) and at 6.48 
(corresponding to the 3-H proton). The 13C NMR spectrum showed a 
quaternary carbon corresponding to the ketone at 200.8 ppm and a peak at 
28.6 ppm, corresponding to the acetyl methyl substituent. The IR spectrum 
was the same as mentioned above, except that there were two carbonyl 
peaks, one at 1731 cm-1 and the other at 1688 cm-1. The high-resolution mass 
spectrum showed a molecular ion species at m/z 335.1530 (C21H21NO3 
requires 335.1521). The melting point of 192 was found to be 91-92 °C. 
 
The next part of our synthesis involved the removal of the Boc protecting 
group on both 191 and 192, followed by the reprotection of the free indole of 
2-(1H-indol-2-yl)benzaldehyde 193 and 1-(2-(1H-indol-2-yl)phenyl)ethanone 
194 with a benzyl substituent, to give 195 and 196. In doing so we would have 
the methylene protons of the N-benzyl substituent which, being acidic, could 
be abstracted by means of a base. The resulting anion could then condense 
with the internal electrophilic aldehyde, or ketone, to afford the fused 
isoquinolines, 179 and 188, after aromatisation of the intermediate alcohols, 
197 and 198, by the loss of water, Scheme 37. 
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Scheme 37: (i) Microwave, silica, 30s intervals (ii) NaH, DMF, BnBr, reflux (iii) KOBut, DMF, 
80 °C, hv (iv) TsOH, CH2Cl2, rt. 
 
The first attempt at removing the Boc protecting group of 191, to form 2-(1H-
indol-2-yl)benzaldehyde 193, involved absorbing 191 onto silica85, using ethyl 
acetate as a solvent, and then irradiating the silica in a microwave at 150 W at 
30 sec. intervals. The reaction progress was monitored by TLC and after 
approximately 13 min. the reaction was stopped, as a mixture of products was 
formed and the starting material had begun to decompose. After purifying the 
reaction mixture by column chromatography, 30% of the starting material was 
recovered. The 1H NMR spectrum of the only new product as shown by TLC 
proved to be very difficult to interpret, but it could be seen that the aldehyde 
proton as well as the methyl protons of the Boc group of the starting material 
191 had disappeared. We speculated that as soon as the Boc protecting 
group was removed, the indole nitrogen condensed with the aldehyde to form 
199, Scheme 38. 
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The 1H NMR spectrum showed that the product 191 was not pure and the 
hydroxyl proton as well as the adjacent proton attached to the neighbouring 
carbon could not be detected. 
 
The second attempt to remove the Boc protecting group of 191 involved the 
use of AlCl3.86 tert-Butyl 2-(2-formylphenyl)-1H-indole-1-carboxylate 191 was 
dissolved in CH2Cl2 and the temperature of the resulting solution was lowered 
to 0 °C. AlCl3 (1.3 equiv.) was added and the reaction mixture was stirred for 
1h before being extracted. After purification by column chromatography, the 
products formed were analyzed by 1H NMR spectroscopy. The spectra of all 
the products formed were very complicated and the products could not be 
readily characterized.  
 
Due to the lack of success in deprotecting 191 under the acidic conditions 
used so far, we decided that we would attempt to deprotect 192, using 
alternative methods. If we were successful in deprotecting the slightly less 
reactive ketone 192, the same methodology could be attempted on the 
aldehyde 191.  
 
The first alternative required dissolving 192 in CH2Cl2 and then adding TFA 
(1.5 equiv.).87 The reaction mixture was stirred for 6h at rt, treated with 
Na2CO3 and then the organic material extracted into CH2Cl2. After purification 
by silica gel column chromatography, a yellow residue was obtained that was 
uncharacterizable by 1H NMR spectroscopy.  
 
Since acidic conditions did not work in the removal of the Boc protecting 
group, we decided to use slightly basic conditions. tert-Butyl 2-(2-
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acetylphenyl)-1H-indole-1-carboxylate 192 was dissolved in THF and a 6M 
sodium methoxide in methanol solution (3 equiv.) was added.88 The reaction 
mixture was stirred for 0.5h at rt. After work up, using 1M HCl, the organic 
material was extracted and purified by column to afford the desired product, 1-
(2-(1H-indole-2-yl)phenyl)ethanone  194, as a whitish-yellow solid in 64% 
yield.  The 1H NMR spectrum showed that the peak at 1.29 ppm, 
corresponding to the methyl groups attached to the quaternary carbon of the 
Boc group, had disappeared and that the indole proton appeared as a singlet 
at 2.77 ppm. The splitting pattern of the aromatic protons had also changed 
significantly: Instead of a doublet, doublet, multiplet and singlet at 8.24, 7.73, 
7.22-7.55 and 6.48 ppm respectively, there was now a multiplet, doublet, 
triplet, triplet, multiplet, triplet and singlet at 7.55-7.60, 7.48, 7.38, 7.29, 7.16-
7.23, 7.08 and 6.53 ppm respectively. The 13C NMR spectrum showed that 
the methyl peak at 27.4 ppm and the C(CH3)3 at 83.2 ppm, belonging to the 
Boc substituent of the starting material, had disappeared indicating that the 
desired deprotection was successful and that 194 had formed.  
 
Having found a successful method for the removal of the Boc substituent of 
192, we decided that we would continue with the synthesis of 5-methyl-6-
phenylindolo[2,1-a]-isoquinoline 188, before attempting to remove the Boc 
protecting group of the related substrated 191 using this method. 
 
The next step in this synthesis was the reprotection of the indole nitrogen, 
using benzyl as the protecting group, to form 1-(2-(1-benzyl-1H-indol-2-
yl)phenyl)ethanoate 196. A solution of 194 in THF was lowered to a 
temperature of –20 °C and NaH (1 equiv.) was added. The solution was 
warmed up to rt and after stirring for 3h, benzyl bromide (1 equiv.) was added 
drop wise. The reaction mixture was stirred, at rt, for a further 72h before it 
was extracted with dichloromethane. The organic residue, after removal of the 
organic solvent, was purified by column chromatography. Three products 
were isolated but all were uncharacterizable by 1H NMR spectroscopy 
(Scheme 39). 
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Scheme 39: BnBr (1 equiv.), NaH (1 equiv.), THF, -20 ˚C Æ r.t. 
 
As a result of the problems encountered with the removal of the Boc group of 
191 and benzylation of the indole nitrogen of 194 during the synthesis of 6-
phenylindolo[2,1-a]isoquinoline 179 and 5-methyl-6-phenylindolo[2,1-
a]isoquinoline 188, it was decided that we pursue an alternative route to the 
synthesis of the desired products. 
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2.2 The Alternative route to the Synthesis of 6-Phenylindolo[2,1-
a]-isoquinoline 179 
 
The first change in the new synthesis we wished to attempt was to swop the 
bromine and boronic acid groups around, hence giving compounds 185, 200 
and 201, (Figure 23) as potential partners for the envisaged Suzuki-Miyaura 
coupling reaction. The indole would have the N-benzyl substituent in place 
before the coupling and thus avoid the deprotection and reprotection strategy 
with a benzyl group as performed previously. 
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Figure 23 
 
Due to the fact that 2-acetylphenyl boronic acid 200, was not commercially 
available, while 2-formylphenylboronic acid 185 was, it was decided that we 
would only continue with the synthesis of 6-phenylindolo[2,1-a]-isoquinoline 
179, from 2-formylphenylboronic acid, using the alternative route. 
 
Many chemists have synthesized 2-bromoindole 202 by using Bergman’s 
conditions.89 This reaction involves the use of t-BuLi, which is not only 
expensive, but t-BuLi also highly flammable and toxic. For these reasons it 
was decided that we would begin with oxindole 203, which we hoped we 
could N-benzylate, followed by the removal of the oxygen of the oxindole and 
replace it with a  bromine. Finally aromatisation would afford 201. Powers90 
has synthesized 2-chloroindole 204 and N-benzyl-2-chloroindole 205 from 
oxindole 203 and N-benzyloxindole 206 respectively, using POCl3. This 
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reaction involved the generation of Vilsmeier salts eg. 207 (salts of imino 
chlorides) by interaction of amides with phosphorus chloride, Scheme 40. 
Powers also found that N-benzyl-2-chloroindole was more stable then 2-
chloroindole. We therefore thought that we would start by benzylating 
oxindole and using similar reaction conditions, using phosphorus oxybromide 
instead of phosphorus oxychloride, we would form 201. 
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Scheme 40: (i) POCl3, CHCl3, reflux. Vilsmeier salt 207 is a protonated form of 2-chloroindole 
204. 
 
We commenced the synthesis of 206, by dissolving oxindole 203 in THF and 
then adding NaH (1 equiv.) to the solution, at rt. Benzyl bromide was added 
and the resulting reaction mixture was allowed to stir for 24h. The reaction 
was extracted, using dichloromethane, to afford a pinkish brown residue. After 
column purification three products were obtained, but were all 
uncharacterizable by 1H NMR spectroscopy (Scheme 41). 
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Scheme 41: (i) BnBr, NaH, THF, rt (ii) BnBr, NaH, DMF, rt (iii) BnBr, K2CO3, DMF, 
microwave. 
 
We decided to modify the procedure slightly by dissolving oxindole 203 in 
DMF, lowering the solution temperature to 0 °C and then adding NaH (1.1 
equiv.).91 The resulting mixture was stirred for 0.5h, at this temperature, 
before being allowed to warm up to rt. The reaction was stirred for 1h and 
benzyl bromide was added drop wise. After stirring the reaction for over 96h, 
the reaction was eventually aborted, as TLC indicated that only base line 
material, indicating probable decomposition, was present.    
 
As a result of the previous two failures, we decided to attempt a different 
procedure. This method involved dissolving a mixture of oxindole 203, K2CO3 
(1 equiv.) and benzyl bromide (1.2 equiv.) in DMF and then exposing the 
resulting mixture to microwave radiation. The mixture was exposed for 2min. 
at 10 sec. intervals with a radiation of 150W. After the solution cooled, water 
was added and an orange precipitate formed. Purification by column 
chromatography afforded three products that were, once again, 
uncharacterizable by 1H NMR spectroscopy.  
 
Due to the reactivity of the 3-position, of oxindole 203, it was thought that 
perhaps the base was not only deprotonating the nitrogen of the indole 5, but 
the 3-position as well, thus resulting in a mixture of products being formed. A 
paper by Grunda92 was also found, where the reactivity of the 3-position as 
well as the problems with benzylation of indole and oxindole, were discussed. 
In attempting to benzylate these two compounds, Grunda formed mono-, di- 
and tri-benzylated compounds, but in very low yields (less then 8%). 
 64
Looking back at Powers’ work we found that he had in fact started with isatin, 
182, which had the 3-postion of oxindole blocked with a carbonyl group. We 
therefore decided to follow his procedure for the synthesis of 1-benzylindolin-
2-one, 206. 
 
The first step in the synthesis of 206 was thus the N-benzylation of isatin. Two 
methods were used to synthesize 1-benzylindoline-2,3-dione 208, Scheme 
43. The first method used the procedure by Azizian et. al93 and made use of 
microwave radiation. Isatin 182, K2CO3 (1 equiv.) and benzyl bromide (3 
equiv.) were dissolved in DMF and exposed to microwave radiation (150W) 
for 2 mins. After the resulting mixture had cooled down, water was added and 
an orange precipitate formed. The precipitate was collected via filtration, 
washed with water and recrystallised from ethanol to afford 208 as orange, 
needle-like crystals in 88% yield. The melting point of 208 was found to be 
133-134 °C, which was relatively close to the literature value of 132-133 °C. 
The 1H NMR spectrum included a singlet, integrating for two protons, at 4.94 
ppm, which corresponded to the NCH2Ph protons and a multiplet, integrating 
for five protons, between 7.25 and 7.38 ppm, corresponding to the benzyl 
aromatic protons. Amongst others, the 13C NMR spectrum showed a peak at 
44.0 ppm corresponding to NCH2Ph carbon. The spectrum also showed the 
presence of an extra aromatic carbon bearing no hydrogens as well as five 
new aromatic carbons, bearing hydrogens, thus indicating that 208 had 
formed. 
 
The second method used the procedure by Garden.94 In this procedure isatin 
182 and CaH2 (1 equiv.) were dissolved in DMF. The solution was stirred for 
1h at a temperature of 100 °C and then lowered to 40 °C so benzyl bromide 
could be added drop wise. The resulting mixture was stirred at 100 °C for a 
further 4 h before being poured into a 0.5M aqueous HCl solution, with 
vigorous stirring. An orange solid subsequently precipitated out, which was 
collected by filtration and purified by recrystallization from CH2Cl2 to afford 
208 as orange needle-like crystals in 89% yield. 
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Scheme 42: (i) K2CO3 (1 equiv.), benzyl bromide (3 equiv.), DMF, microwave radiation, 2 
min. or (ii) CaH2 (1 equiv.) DMF, 1 h, 100 °C, then 40 °C, benzyl bromide, then 4h, 100 °C. 
 
The next step in the synthesis of 206, following Powers’ procedure, was the 
functional group interconversion of the oxygen atom in the 3-position to two 
chlorine atoms to form 1-benzyl-3,3-dichloroindolin-2-one, 209. PCl5 was 
added to a solution of 208 in benzene. The resulting mixture was maintained 
at 25 °C for 24h to obtain a brown residue, after the solvent was removed, 
which was purified by column chromatography to afford 209 as a light yellow 
oil. On addition of ethanol, 209 precipitated out as a white solid in 81% yield. 
The melting point of 209 was found to be 125-126 °C. The 1H NMR spectrum 
was slightly different to the starting material. The triplet at 7.48 ppm and the 
multiplet between 7.25 and 7.38 ppm now overlapped to form a multiplet 
between 7.22 and 7.39 ppm and integrated for 6 protons. The 13C NMR 
spectrum had also changed slightly as the quaternary carbon corresponding 
to C-9 was not evident and now coincided with the signal at 124.2 ppm.  
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Scheme 43: (i) 1-benzyl-indolin-2,3-dione, benzene, PCl5, 25 °C, 24 h. 
 
After recrystallization of 209 from ethanol, rectangular, clear crystals were 
obtained and a crystal x-ray diffraction was performed, confirming that 209 
had formed. The bond lengths and angles were found to be within the 
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average bond lengths and angles expected for this type of structure. Although 
the molecule itself was not centrosymmetric the crystal overall was found to 
be centrosymmetric (Figure 24). 
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Figure 24: (i) Crystal structure of 1-benzyl-3,3-dichloroindolin-2-one 209. (ii) Molecular 
structure of 209. (iii) Unit cell packing of 209 showing crystal is centrosymmetric. 
 
Now that 209 had been synthesized, the next step was to form 1-
benzylindolinone 206. The first method applied was one of hydrogenation 
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using Adams catalyst (PtO2), in acetic acid. Adams catalyst (10 mol%) was 
therefor added to a solution of 209 in acetic acid (Scheme 44). The resulting 
mixture was stirred under a hydrogen atmosphere for 6h before the catalyst 
was removed by filteration and most of the solvent removed. The remaining 
acetic acid was neutralized with aqueous NaHCO3 and the solution was 
extracted using CH2Cl2. The solvent was then removed and the organic 
residue obtained was purified by column chromatography to afford 206 as a 
yellow oil, that eventually, on standing, formed a white solid. Starting material 
was also recovered from the reaction. The yield for this reaction was variable 
and normally between 38 and 48%, although we did once manage to obtain 
206 in 79%. 
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Scheme 44: (i) PtO2 (10 mol%), AcOH, H2 Atm., rt or (ii) Zn, AcOH, rt. 
 
Zimmerman and Mais95 did a study on the stereochemistry of the ketonization 
of the 1,9-enol of 1-decalone 210 and found that the debromination of α-
bromoketones with zinc and a proton donor (such as acetic acid) generated 
unstable enols 211, which tautomerised very readily to the ketone 212, 
Scheme 45.  
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Scheme 45: Zimmerman and co-workers’ debromination with zinc and acetic acid (a) to form 
the unstable enol 211 that tautomerises to form the more stable ketone 212 
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The second method attempted by us in order to dechlorinate 209 to afford 206 
was hence Zimmerman’s debromination reaction conditions. The synthesis 
commenced by adding activated zinc (15 equiv.) to a solution of 209 in acetic 
acid, over a 10 min. period. The resulting mixture was stirred for a further 10 
min. before the zinc was filtered off, the solution neutralized with NaHCO3 and 
then the organic material was extracted with diethylether. After purification by 
column chromatography, 206 was afforded as a white solid in 76% yield. The 
purification of 206 by recrystalisation was attempted using hot ethanol and 
dichloromethane layered with hexane, but only ethanol layered with hexane 
resulted in suitable crystals. The melting point was found to be 60-62 °C.  
 
The 1H NMR spectrum of 1-benzylindolin-2-one from both procedures showed 
a new singlet at 3.62 ppm, integrating for two protons, which corresponded to 
the 3-H protons. There was also a new signal in the 13C NMR spectrum at 
35.7 ppm, which corresponded to the carbon containing the same protons, 
indicating that 206 had formed. 
 
Now that we had 1-benzylindolin-2-one 206, the next step was to brominate 
the 2-positon, presumably by way of the enol, to obtain 1-benzyl-2-bromo-1H-
indole 201 (Scheme 46). Various solvents, reagents known to replace a 
carbonyl with a halogen and additives were tried in order to try optimise the 
yield of this reaction. Table 1 shows the various reaction conditions employed 
(all reactions were performed at reflux). 
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Scheme 46: See table 1 for reaction conditions 
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Solvent Br Agent Additive Time of 
reflux (h) 
Yield 
DCM POBr3 imidazole96 72 50% + 20% SM 
DCM POBr3 none 48 55% 
DCE POBr3 none 24 - 
DCE POBr3 imidazole 24 - 
CH3CN PBr3 none 72 7% 
Table 1: DCM = dichloromethane, DCE = dichloroethane, CH3CN = acetonitrile, POBr3 = 
phosphorus oxybromide, PBr3 = phosphorus tribromide, SM = starting material 
 
From the table it can be seen that heating 206 at reflux in DCE, with and 
without an additive, only resulted in uncharacterizable material being isolated. 
In the case of 206 in CH3CN, using PBr3 as a brominating agent, a mixture of 
5 different products were isolated.  The desired product was formed in 7% 
yield as a white solid, while the other products formed were uncharacterizable 
by 1H NMR spectroscopy. Heating 1-benzylindolin-2-one 206 at reflux in a 
solution of POBr3 and DCM gave a much higher yield of 55%. Performing this 
reaction in the presence of imidazole however, resulted in 20% of the starting 
material being recovered and 50% of the desired product being isolated. Thus 
taking into account the unreacted starting material a yield of 88% of 201 was 
obtained. In solution 201 was found to decompose within a few hours but if 
left in the solid state, in a refrigerator, the compound was found to be stable 
for months. The melting point of 201 was found to be 87-89 °C. The 1H NMR 
spectrum showed that the singlet peak at 3.62 ppm was no longer evident and 
a singlet, now integrating for one proton, appeared at 6.65 ppm. The 13C NMR 
spectrum showed that the peak at 35.7 ppm, corresponding to 3-C had 
disappeared and a new peak, corresponding to the 3-C of the indole nucleus, 
at 104.5 ppm had appeared. The carbonyl peak at 175.1 ppm was no longer 
seen and a carbon, corresponding to the carbon attached to the bromine 
atom, had appeared. High-resolution mass spectroscopy showed a molecular 
ion species at m/z 285.0091 (C15H12N79Br requires 285.0153), indicating that 
201 had formed. The IR spectrum showed the presence of a C-Br stretch at 
691 cm-1 and an ArC=C stretch at 1605 cm-1. There were no signals in the 
C=O region (1650-1750 cm-1) supporting the evidence that the carbonyl had 
been successfully converted to the desired product 201. 
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Now that the brominated compound 201 had been synthesized, the next step 
of the synthesis was to couple 201 with 2-formylphenylboronic acid 185, using 
Suzuki-Miyaura coupling conditions. Under a nitrogen atmosphere, a solution 
of 1-benzyl-2-bromo-1H-indole 201, 2-formylphenylboronic acid 185 (1.5 
equiv.) and DME were added to a round bottom flask containing 10 mol % of 
Pd(PPh3)4. To the resulting mixture, a 2M Na2CO3 solution (5 equiv.) was 
added. The mixture was heated at reflux for 24h and then extracted using 
ethyl acetate. Once the organic solvent was removed, the residue was 
purified by column chromatography to afford 2-(1-benzyl-1H-indol-2-
yl)benzaldehyde 195 as a yellow, viscous oil in 92% yield. The IR spectrum 
showed that the product 195 (Scheme 47) had formed, as there was a 
carbonyl carbon peak present at 1710 cm-1.  The 1H NMR spectrum also 
showed the presence of an aldehyde proton at 9.85 ppm and the 13C NMR 
spectrum showed the presence of an aldehyde carbon at 191.6 ppm. High 
resolution mass spectroscopy showed the expected molecular ion at m/z 
311.1335 (C22H17NO requires 311.1310). 
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Scheme 47: (i) Pd(PPh3)4 (10 mol%), DME, Na2CO3 (5 equiv.), Reflux, 24 h, 92%. 
 
Previously, in our laboratory, it had been found that our well-developed 
reaction conditions for forming aromatic rings required the presence of a UV 
light source.77 Other similar experiments however, showed that the light 
source was not always required. Using tBuOK and DMF at 80 °C co-workers 
were able to synthesize indolo[2,1-a]isoquinolines and pyrrolo[2,1-
a]isquinolines.4,39,77,79 In some cases however, it was found that the 
intermediate alcohol 213, as shown in Scheme 48, was stable and an 
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additional step (elimination of water) had to be under taken in order to obtain 
the aromatic product 214. The difference in our synthesis compared to the 
previous synthesis, if successful, is that the methyls substituents at the 5- and 
12-positions of the product would be absent.  
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Scheme 48: (i) tBuOK, DMF, 80 °C  (ii) 15 mol% TsOH, CH2Cl2, rt, 24 h. 
 
In the synthesis of 6-phenylindolo[2,1-a]-isoquinoline 179, we found that by 
stirring a mixture of 2-(1-benzyl-1H-indol-2-yl)benzaldehyde 195 and tBuOK 
(1.2 equiv.) in DMF, at rt for 2min, a mixture of syn- 216 and anti-5,6-dihydro-
6-phenylindolo[2,1-a]isoquinolin-5ol 217 diastereomers were obtained in 78% 
yield (Scheme 49). Both diastereomers were found to be yellow-green resins 
in a ratio of 7:3 i.e. 53% anti and 22% syn. On TLC plates the Rf’s were found 
to be quite different (0.12 difference in a 30% mixture of ethyl acetate/hexane 
as solvent).  
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Scheme 49: (i) tBuOK, DMF, rt, 2 min 
 
The diastereomers of 216 and 217 (Scheme 49) were separated by column 
chromatography and were analyzed by the usual methods. The IR spectra of 
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both revealed the presence of a broad OH peak at 3423 and 3364 cm-1 for the 
anti- and syn- diastereomers respectively. The 1H NMR spectrum of the anti- 
diastereomer 216 showed that the peak at 5.26 ppm, corresponding to the 
methylene protons of the benzyl group, and the aldehyde proton which was 
visible at 9.85 ppm in the starting material had disappeared. The 1H NMR 
spectrum however showed the presence of a hydroxyl, as a doublet, at 1.66 
ppm (J = 11.0 Hz), the benzylic proton attached to the hydroxyl, as a double 
doublet, at 5.38 ppm (J = 7.0 and 11.0 Hz) and the benzylic proton attached to 
the nitrogen, as a doublet, at 5.71 ppm (J = 6.9 Hz). From the coupling 
constants it can be seen that the hydroxyl proton is coupled to the benzylic 
proton attached to the hydroxyl, which is also coupled to the benzylic proton 
attached to the nitrogen. The aromatic region was found to be very 
complicated but integrated for fourteen protons as expected. The 13C NMR 
spectrum showed that the carbonyl carbon and the methylene carbon peaks 
at 191.6 and 47.6 ppm respectively had disappeared and that there were two 
new peaks at 59.5 and 69.5 ppm corresponding to the C-5 and C-6 
respectively. The spectrum also indicated the presence of 18 aromatic 
carbons as expected. High resolution mass spectroscopy showed a molecular 
ion species at m/z 311.1302 (C22H17NO requires 311.1310). 
 
The 1H NMR spectrum for the syn-diastereomer 217 was different and 
showed the presence of a very broad singlet at 2.18 ppm, corresponding to 
the hydroxyl proton, a slightly broad singlet at 4.91, corresponding to the 
benzylic proton attached to the hydroxyl and a doublet at 5.81 ppm, 
corresponding to the benzylic proton attached to the nitrogen (J = 1.5 Hz). 
Looking at the size of the coupling constant we can see that it is far smaller 
than the other diastereomer and thus based on this, the anti- and syn-
diasteroemers were assigned. The aromatic region of the 1H NMR spectrum 
was also fairly complicated, but the region integrated for 14 protons as 
expected. The C-5 and C-6 carbon peaks were found, on the 13C NMR 
spectrum, at 62.0 and 73.9 ppm respectively. Although the spectrum showed 
18 aromatic carbon signals they were at slightly different peak shifts 
compared to the anti-diastereomer 216. High resolution mass spectroscopy 
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found the molecular ion for the syn-diastereomer 217 to be at m/z 311.1339, 
where C22H17NO requires 311.1310. 
 
The final step in the synthesis of 6-phenylindolo[2,1-a]-isoquinoline 179 was 
the dehydration of 216 and 217. This step commenced by dissolving a mixture 
5,6-dihydro-6-phenylindolo[2,1-a]isoquinolin-5-ol diastereomers, 216 and 217, 
in CH2Cl2 and adding activated molecular sieves. First pTSA was added in 
order to try and dehydrate 216 and 217, but after heating at reflux for 48h, 
only approximately 3% of the diastereomeric mixture had converted into 
another compound. A few drops of concentrated sulfuric acid were added and 
after 5h, a further 10 drops were added, but the conversion still had not 
progressed. The mixture was left stirring at reflux for a further 10h, which 
resulted in the reaction mixture decomposing. The dehydration of 216 and 
217 were unsuccessful and 6-phenylindolo[2,1-a]-isoquinoline 179 was 
unfortunately not obtained. Clearly this is a step that can be accomplished, 
but time precluded attempting other methods for achieving this transformation. 
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Scheme 50: (i) p-TsOH, CH2Cl2, reflux 48 h. 
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2.3. The Synthesis of Ethyl Indolo[2,1-a]isoquinoline-6-
carboxylate 183 using the Alternative Route 
 
The successful synthesis of (±)-5,6-dihydro-6-phenylindolo[2,1-a]isoquinolin-
5ol 216/217, starting from isatin, led us to attempt the synthesis of  ethyl 
indolo[2,1-a]isoquinoline-6-carboxylate 183 using this route. 
 
The first step in the synthesis of 183 was the protection of isatin 182 with ethyl 
2-acetate (Scheme 51). This was done using CaH2 as a base on both small 
scale (440 mg) and large scale (10 g). Garden et. al94 found that the alkylation 
of isatin 182, with various protecting groups, using CaH2 in DMF occurred 
more smoothly in wet DMF then in previously dried DMF, indicating that the 
base involved was probably the hydroxide ion and not the hydride itself. In 
both small scale and large-scale procedures, isatin 182 and CaH2 (3.3 equiv. 
small scale and 1.0 equiv. large scale) were dissolved in wet DMF.  The 
small-scale procedure was stirred at 45 °C for 0.5 h before adding ethyl 2-
bromoacetate and then stirring for a further 24h. The large scale was stirred at 
100 °C for 1h before adding ethyl 2-bromoacetate and then stirring for a 
further 4h. In both procedures the resulting mixture was poured into an 
aqueous dilute HCl solution. The small-scale reaction was extracted with 
ether and purified by column chromatography to obtain ethyl 2-(2,3-
dioxoindolin-1-yl)acetate 218 as a bright yellow solid in 83% yield. For the 
large-scale reaction, 218 precipitated as a yellow solid that was purified by 
recrystallisation with a hexane-dichloromethane mixture, in quantitative yield. 
The melting point was found to be 132-133 °C. The IR spectrum showed a 
C=O band at 1740 cm-1 and an ArC=C band at 1615 cm-1. 
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Scheme 51: (i) CaH2, DMF 
 
The 1H NMR spectrum displayed a triplet at 1.29 ppm, corresponding to the 
methyl protons, a quartet at 4.25 ppm, corresponding to the methylene 
protons of the ethyl group and a singlet at 4.49 ppm, corresponding to the 
methylene protons. The aromatic region integrated for 4 protons and was 
made up of a doublet at 6.79 ppm, an apparent triplet at 7.16 ppm, an 
apparent double triplet at 7.59 ppm and a doublet at 7.66 ppm. In addition, the 
13C NMR spectrum showed the presence of 5 quaternary carbons and 4 
aromatic protons as expected. The methyl carbon was found at 14.1 ppm, the 
methylene carbon attached to the nitrogen at 41.3 ppm and the methylene 
carbon of the ethyl group at 62.2 ppm. High-resolution mass spectroscopy 
showed a molecular ion species at 233.0675 (C12H11NO4 requires 233.0688) 
indicating that 218 had formed. 
 
The next step was the functional group interconversion of ethyl 2-(2,3-
dioxoindolin-1-yl)acetate 218 to  ethyl 2-(3,3-dichloro-2-oxoindolin-1-yl)acetate 
219. This was done as before using PCl5 in benzene at 25 °C for 24h 
(Scheme 52). After purification by column chromatography, 219 was obtained 
as a white solid in quantitative yield. The melting point was found to be 115-
116 °C. The IR spectrum showed the presence of a C-Cl peak at 670 cm-1. 
The methyl and methylene peaks had the same splitting pattern and chemical 
shift on both the 1H and 13C NMR spectra as in compound 218. However, the 
aromatic region of the 1H NMR spectrum had changed slightly: the apparent 
double triplet was no longer at 7.59 ppm but instead had shifted up field 
slightly to 7.39 ppm. The 13C NMR spectrum still had 9 aromatic carbon 
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signals, however the PhC=O carbon had shifted from 184.2 ppm to 73.9 ppm 
indicating that a change in functional group had occurred. High-resolution 
mass spectroscopy showed a molecular ion at m/z 287.0151 (C12H11NO35Cl2 
requires 287.0116). 
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Scheme 52: (i) PCl5, Benzene, 25 °C, 24 h. 
 
The next step in the synthesis was the Zimmerman95 dechlorination reaction 
using zinc in acetic acid. The dichloro compound 219 (Scheme 53) was 
dissolved in acetic acid and activated zinc (14 equiv.) was added over a 10 
min period. The resulting mixture was stirred for a further 5 min. before the 
zinc was filtered off and most of the acetic acid removed. The remaining 
acetic acid was thus neutralized using a concentrated NaHCO3 solution, the 
solution was extracted with ether and the resulting residue was purified by 
column chromatography to afford ethyl 2-(2-oxoindolin-1-yl)acetate 220, as a 
white solid in quantitative yield. The melting point of 220 was found to be 127-
129 °C. The IR spectrum had no significant changes except that instead of a 
broad C=O peak at 1746 cm-1, there were two sharp peaks at 1740 and 1715 
cm-1. The 1H NMR spectrum showed a new signal at 3.60 ppm, integrating for 
the 2 protons adjacent to the amide functional group. The 2 aromatic protons’ 
signals at 7.39 and 7.66 ppm were now overlapping one another to form a 
multiplet between 7.23 and 7.28 ppm. The 13C NMR spectrum showed the 
methyl and methylene carbons in the same place as before, but a new signal 
at 35.5 ppm, corresponding to the new methylene carbon, was now present. 
The spectrum also showed the presence of 8 aromatic carbons as expected. 
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High-resolution mass spectroscopy showed a molecular species present at 
m/z 219.0896 (C12H13NO3 requires 219.0895). 
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Scheme 53: (i) Zn (14 equiv.), AcOH, rt, 15 min. 
 
As in the synthesis of 1-benzyl-2-bromo-1H-indole 201, the synthesis of ethyl 
2-(2-bromo-1H-indole-1-yl)acetate 184 was performed under various reaction 
conditions in order to try and optimize the yield (Scheme 54). Table 2 shows 
the reaction conditions and the results obtained (once again all reactions were 
performed under reflux).  
 
Solvent Br Agent Additive Time of Reflux 
(h) 
Yield 
DCM POBr3 none 216 (9 days) 48% + 30% SM 
DCM POBr3 imidazole96 48 40% SM 
DCE POBr3 none 24 - 
DCE POBr3 imidazole 48 30% 
CH3CN PBr3 none 96 95% SM 
Table 2: DCM = dichloromethane, DCE = dichloroethane, CH3CN = acetonitrile, POBr3 = 
phosphorus oxybromide, PBr3 = phosphorus tribromide, SM = starting material 
 
From the table it can be seen that the results vary significantly with and 
without imidazole. Heating 220 at reflux in dichloroethane in the absence of 
imidazole resulted in only uncharacterizable material being isolated, while in 
the presence of imidazole, the product 184 was obtained in 30% yield as a 
white solid. Heating 220 at reflux in dichloromethane seemed to have the 
opposite effect. In the presence of imidazole, 40% of the starting material, 
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220, was recovered as well as some uncharacterizable material. In the 
absence of imidazole however, 30% of the starting material was recovered 
and 48% of the desired product was isolated (a 69% yield taking into account 
the recovered starting material). Heating 220 at reflux in CH3CN, using PBr3 
as the brominating agent, seemed to have little or no effect on the starting 
material even after 4 days. 
 
Analysis of ethyl 2-(2-bromo-1H-indole-1-yl)acetate 184 by IR spectroscopy 
showed the presence of a C-Br peak at 606 cm-1 and a carbonyl peak at 1737 
cm-1. A singlet at 6.63 ppm corresponding to the 3-H proton could be seen in 
the 1H NMR spectrum. The carbonyl peak at 174.9 ppm and the methylene 
carbon signal at 35.5 ppm had disappeared and a new aromatic carbon signal 
at 105.1 ppm had appeared in the 13C NMR spectrum. Further more, high-
resolution mass spectroscopy supported the evidence that 184 had formed as 
a molecular ion at m/z 281.0052 (C12H12NO279Br requires 281.0051) was 
present. The melting point of 184 was found to be 61-63 °C.  
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Scheme 54: (i) See Table 2 for reaction conditions 
 
Now that the brominated compound 184 had been formed, the next step was 
to couple it with 2-formylphenylboronic acid 185 using Suzuki-Miyaura 
coupling conditions. Following the procedure from before, a mixture of the 
bromide 184, the boronic acid 185 (1.5 equiv.), Pd(PPh3)4 (10 mol%), 2M 
Na2CO3 (5 equiv.) and DME were heated at reflux for a very short time, under 
a nitrogen atmosphere. Extraction of the organic material with ethyl acetate 
followed by the purification, by column chromatography, of the residue 
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afforded ethyl 2-(2-(2-formylphenyl)-1H-indol-1-yl)acetate 186 as an orange, 
viscous oil in 77% yield (Scheme 55).  
 
IR spectroscopy showed the presence of both an aldehyde and an ester 
carbonyl at 1748 and 1693 cm-1 respectively. The 1H NMR and 13C NMR 
spectra showed the presence of an aldehyde proton and carbonyl carbon at 
10.00 and 192.1 ppm respectively. In addition, high-resolution mass 
spectroscopy showed a molecular ion at m/z 307.1200 (C19H17NO3 requires 
307.1208) indicating that 186 had formed.  
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Scheme 55: (i) Boronic acid 185 (1.5 equiv.), Pd(PPh3)4 (10 mol%), 2M Na2CO3 (5 equiv.), 
DME, reflux, 10 min. (ii) tBuOK (10 mol%), DMF, rt, 2 min. 
 
The final step in the synthesis of ethyl indolo[2,1-a]isoquinoline-6-carboxylate 
183 was to convert ethyl 2-(2-(2-formylphenyl)-1H-indol-1-yl)acetate 186 to 
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183 using our well developed reaction conditions. We commenced the 
synthesis by adding tBuOK (10 mol%) to a solution of 186 in DMF at room 
temperature.  The reaction was stirred at this temperature for 2 minutes 
before it was quenched with water and the organic material extracted with 
diethylether. The resulting residue was then purified by column 
chromatography to afford 183 as a yellow-orange solid in 59% yield. When 
monitoring the reaction by TLC we were able to see the formation of two new 
spots (presumably the diastereomeric alcohols 221 (only one spot visible - Rfs 
overlapping) and the dehydrated product 183) and then the disappearance of 
the alcohol 221 as dehydration took place and the aromatic carboxylate 183 
was formed. Just like 5,6-dihydro-6-phenylindolo[2,1-a]isoquinolin-5-ol 216 
and 217, the product 183 fluoresced intensely under UV light (Figure 25). 
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Figure 25: TLC plates showing the appearance of 2 new spots and then the disappearance 
of spot 2 (presumably the alcohol diastereomers) after 2 minutes. S.M = Starting Material, P = 
Product, A = TLC just after addition of tBuOK, B= TLC 2 minutes after adding tBuOK. 
 
The IR spectrum showed the presence of an ArC-H stretching band at 3000 
cm-1, a C=O band at 1724 cm-1, an ArC=C band at 1601 cm-1 and an Ar-H 
band at 738 cm-1. In addition, the aldehyde proton’s signal at 10.00 ppm as 
well as the methylene protons’ signal at 4.71 ppm had disappeared in the 1H 
NMR spectrum. The 13C NMR spectrum supported the 1H NMR spectrum by 
showing the disappearance of the aldehyde carbonyl carbon signal at 192.1 
ppm and the methylene carbon signal at 45.7 ppm. The 1H NMR spectrum 
showed that there was another aromatic proton (the 5-H proton) present as 
the aromatic region integrated for ten protons and not nine as before. The 13C 
NMR spectrum also revealed the presence of a new aromatic carbon as well 
as a new quaternary carbon (C-6). The high-resolution mass spectroscopy 
spectrum supported the NMR spectra as a molecular ion was found to be 
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present at m/z 289.1081 (C19H15NO2 requires 289.1103), indicating that 183 
had successfully been synthesized. Ethyl indolo[2,1-a]isoquinoline-6-
carboxylate 183 was found to have a melting point of 109-110 ºC. 
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Chapter 3: Conclusion and Outlook 
 
In conclusion we have managed to successfully synthesize ethyl indolo[2,1-
a]isoquinoline-6-carboxylate 183 and (±)-5,6-dihydro-6-phenylindolo[2,1-
a]isoquinolin-5-ol 216/217, (Figure 26) in moderate to high yields, using as  
key steps the Suzuki-Miyaura cross coupling reaction and our novel 
cylclisation reaction conditions (tBuOK, DMF, rt). 
 
N
H O
H
H
N
O
O
183 216/217  
Figure 26 
 
The initial attempted synthesis of 6-phenylindolo[2,1-a]isoquinoline 179, 
starting from indole 5, was found to be highly problematic i.e. removal of the 
Boc protecting group and reprotection of the indole nitrogen with a benzyl 
were difficult. The alternative route starting from isatin 182 was not only a 
cheaper and safer route, but was far less problematic, Scheme 55. The 
bromination reaction to afford 201 was the only moderate yielding step with a 
yield of approximately 55%. We managed to synthesize a mixture of 
diastereomers of 216/217 in 75% yield from 195, but failed to dehydrate this 
compound by heating it at reflux in CH2Cl2 in the presence of pTSA and 
activated molecular sieves (Scheme 56).  
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Scheme 56: (i) Initial attempted synthesis of 179 starting from indole 5. (ii) Alternative route 
used to synthesize 179 starting from isatin 182. (iii) Final step in the synthesis of 179 failed 
using pTSA, activated molecular sieves, CH2Cl2, reflux. 
 
Alternative reaction conditions that could be used to convert 216/217 to 179 
are to either repeat the reaction using another acid or to convert the hydroxyl 
substituent of 216/217 into a better leaving group such a mesylate (OMs) or 
triflate (OTf) 222. Removal of this group should result in the formation of the 
desired alkene 179 as shown in Scheme 57. 
 
N
H OR
H
N
H
R = Tf or Ms
179222  
Scheme 57 
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Having successfully synthesized 183 using the alternative reaction conditions 
(starting from isatin 182), the next step would be to remove the ester group 
and obtain the indolo[2,1-a]isoquinoline skeleton 8 (Schme 58). The first step 
would be to convert the ester group into an acid 187. Once the acid is 
obtained we could use Barton decarboxylation97 to afford 8. This 
decarboxylation involves protecting the acid OH with 223 in the presence of 
DCC and DMAP to form 224, which then undergoes radical decarboxylation 
with Bu3SnH to afford 8 in the presence of a radical initiator such as AIBN. 
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Scheme 58: Barton Decarboxylation 
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Chapter 4: Experimental Procedures 
 
4.1. General Experimental Procedures 
 
4.1.1. Purification of Solvents and Reagents 
 
All solvents used for reactions and preparative silica gel chromatography were 
distilled prior to use. Tetrahydrofuran and diethyl ether were distilled from 
sodium benzophenone ketyl radical; dichloromethane, and dimethyl 
formamide from calcium hydride; benzene from sodium. Potassium tert-
butoxide was sublimed prior to use. Chloroform was dried by passage through 
basic alumina (ICN Adsorbentien, ICN Alumina Super I). When necessary, 
solvents were stored over activated molecular sieves (4Å) under a nitrogen 
atmosphere. Unless otherwise noted, other reagents were obtained from 
commercial sources and used without further purification. 
 
4.1.2. Chromatographic Separations 
 
The Rf values quoted are for thin layer chromatography (TLC) on aluminium-
backed Macherey-Nagel Alugram Sil G/UV254 plates pre-coated 0.25 mm 
silica gel 60, detection by UV-absorption. Preparative silica gel column 
chromatography was carried out both on wet- and dry-packed columns using 
Macherey-Nagel Kieselgel 60 silica gel 60 (particle size 0.063-0.200 mm) as 
the adsorbent. Mixtures of ethyl acetate and hexane were used as the mobile 
phase. 
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4.1.3. Spectroscopic and Physical Data 
 
All melting points were obtained on a Reichert hot-stage microscope and are 
uncorrected. 
 
1H NMR (nuclear magnetic resonance) spectra were recorded on a Bruker 
AC-200 (200.13 MHz) or Bruker AVANCE 300 (300.13 MHz) spectrometer 
respectively. Spectra were recorded in deuterated chloroform (CDCl3) unless 
otherwise specified and chemical shifts are reported in parts per million 
downfield from tetramethylsilane, the internal standard; coupling constants are 
given in Hertz. Splitting patterns are designated as “s”, “d”, “dd”, “t”, “q”, “m”, 
“br”, and “quat”; these symbols indicate “singlet”, “doublet”, “double doublet”, 
“triplet”, “quartet”, “multiplet”, “broad” and quaternary, respectively. NMR 
spectral data are reported as follows: chemical shift (integration of signal, 
description of signal, coupling constant(s) where applicable, assignment). 
 
13C NMR (1H decoupled) spectra were recorded on a Bruker AC-200 (50.32 
MHz) or Bruker AVANCE 300 (75.47 MHz) spectrometer respectively. Spectra 
were recorded in deuterated chloroform (CDCl3) unless otherwise specified 
and chemical shifts are reported in parts per million relative to the central 
signal of deuterated chloroform, taken as δ 77.00. 
 
IR (infrared) spectra were recorded on a Bruker IFS-25 Fourier Transform 
spectrometer. Liquid samples were recorded as thin films between sodium 
chloride plates, while solid samples were recorded as solutions in chloroform 
between sodium chloride plates. Brominated compounds were run as KBr 
pellets. The signals are reported on the wavenumber scale (ν/ cm-1). IR 
spectra data are reported as follows: wavenumber (assignment). 
 
High-resolution mass spectra (HRMS) were recorded on a VG70 MS (Mass 
Spectrum CC Pyramid data system), or on a VG70 SEQ (VG 11-250J or Marc 
II data systems). Mass spectroscopy values are reported as m/z. 
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4.1.4. Crystal Structure Data and Refinement 
 
Intensity data were collected on a Bruker SMART 1K CCD area detector 
diffractometer with graphite monochromated Mo Kα radiation (50kV, 30mA). 
The collection method involved ω-scans of width 0.3°. Data reduction was 
carried out using the program SAINT+. The crystal structure was solved by 
direct methods using SHELXL-97. Diagrams were generated using PLATON 
and GSview. 
4.1.5. Other General Procedures 
 
The term “removal of solvent under reduced pressure” refers to the use of 
aspirator pressure (ca. 25 Torr) with a Rotavapor at 40-50 oC. The term “in 
vacuo” refers to removal of solvent by rotary evaporation, followed by removal 
of the residual solvent at oil pump pressure (ca. 0.1-1.0 Torr) at ambient 
temperature until constant mass was achieved. 
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4.2. Experimental Procedures Related to Chapter 2 
 
4.2.1. Experimental Procedures for the Attempted Synthesis of 6-
Phenylindolo[2,1-a]isoquinoline 179 and 5-Methyl-6-
phenylindolo[2,1-a]isoquinoline 188 
 
4.2.1.1. Synthesis of tert-Butyl 1H-indole-1-carboxylate 18981 
 
1
2
34
5
6 N
7
O
O
189  
 
Boc2O (25.0 cm3, 110 mmol, 1.3 equiv.) and DMAP (0.50 g, 4.1 mmol, 5 mol 
%) were added to a solution of indole (10 g, 85 mmol) in tetrahydrofuran (250 
cm3). The resulting mixture was stirred at room temperature for 24 h, under 
nitrogen. Water (50 cm3) was added and the solution was extracted with ethyl 
acetate (3 × 50 cm3). The organic layers were combined and dried with 
anhydrous magnesium sulfate. The solvent was removed in vacuo and 
purified by distillation (120 °C, 1 atm) to obtain 189 as a clear oil (14.70 g, 
79%). Rf = 0.60 (5% ethyl acetate/hexane); 1H NMR (300 MHz; CDCl3; 
Me4Si): δH (ppm) = 1.66 (9H, s, 3×CH3), 6.55 (1H, d, J=3.6 Hz, 3-H), 7.19-
7.33 (2H, m, 2×ArH), 7.55 (1H, d, J=7.5 Hz, 4-H), 7.59 (1H, d, J=3.6 Hz, 2-H), 
8.15 (1H, d, J=8.1 Hz, ArH). 
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4.2.1.2. Synthesis of 1-(tert-Butoxycarbonyl)-1H-indol-2-yl-2-boronic acid 
19082 
 
190
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A 250 cm3 round bottom flask equipped with a dropping funnel, rubber septum 
and nitrogen adaptor was flame dried. Tetrahydrofuran (25 cm3 and 100 cm3) 
was added to the dropping funnel and round bottom flask respectively. 
Tetramethylpiperidine (2.04 cm3, 12.0 mmol, 1.3 equiv.) was added to the 
flask via syringe and tert-Butyl 1H-indole-1-carboxylate (2.00 g, 9.20 mmol) 
189 was added to the dropping funnel. The solution was lowered to –78 ºC 
and butyl lithium (7.9 cm3, 11 mmol, 1.2 equiv.) was added drop wise, via 
syringe, over 5 min. The solution was warmed to 0 ºC over 30 min. and then 
recooled to –78 ºC. The solution in the dropping funnel was now added drop 
wise to the flask and the resulting mixture was stirred for 1.5 h at –78 ºC. 
B(OMe)3 (5.16 cm3, 46.0 mmol, 5 equiv.) was added and the solution was 
stirred at –78 ºC for a further 30 min before allowing to warm up to room 
temperature. Water (150 cm3) was added, the solution was acidified using an 
aqueous 1 M HCl solution and then extracted with ether (3 × 100 cm3). The 
organic layers were combined, washed with brine and dried with anhydrous 
magnesium sulfate. The solvent was removed, in vacuo, until approximately 
15 cm3 remained. Cold hexane was added which resulted in 1-(tert-
butoxycarbonyl)-1H-indol-2-yl-2-boronic acid 190 precipitated out as a white 
solid (1.57 g, 65%). The solid product 190 was obtained via filtration, dried 
overnight under nitrogen and stored in a refrigerator. Rf = 0.1 (20% ethyl 
acetate/hexane); 1H NMR (300 MHz; CDCl3; Me4Si): δH (ppm) = 1.74 (9H, s, 
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3×CH3), 7.25 (1H, t, J=7.4 Hz, ArH), 7.35 (1H, m, ArH), 7.50 (1H, s, 3-H), 7.54 
(2H, s, 2×OH), 7.60 (1H, d, J=7.6 Hz, ArH), 8.02 (1H, d, J=8.4 Hz, ArH). 
 
4.2.1.3. Synthesis of tert-Butyl 2-(2-formylphenyl)-1H-indole-1-
carboxylate 19183 
 
191
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Tetrakis(triphenylphosphine)palladium(0) (0.53 g, 0.46 mmol, 10 mol %) was 
added to a 50 cm3 flame dried, round bottom flask, equipped with a 
condenser and dropping funnel. The boronic acid 190 (1.80 g, 6.89 mmol, 1.5 
equiv.), 2-bromobenzaldehyde (0.85 g, 4.6 mmol) and DME (12 cm3), were 
combined in the dropping funnel and degassed before adding it to the flask. A 
2M Na2CO3 solution (2.44 g, 23.0 mmol, 5 equiv.) was added to the dropping 
funnel, degassed and then added to the flask. The dropping funnel was 
closed and the resulting mixture was degassed once more before heating 
under reflux for 72 h. Water (50 cm3) was added and the solution was 
extracted with ethyl acetate (3 × 50 cm3). The organic layers were combined 
and dried with anhydrous magnesium sulfate. The solvent was removed in 
vacuo and the residue was purified by column chromatography (2% ethyl 
acetate/hexane) to afford tert-butyl 2-(2-formylphenyl)-1H-indole-1-
carboxylate 191 as a white solid (1.26 g, 85%). Rf = 0.44 (10% ethyl 
acetate/hexane); m.p. 127-128 ºC; νmax (film)/cm-1: 2980 (ArC-H), 1733 and 
1698 (C=O), 1600 (ArC=C), 1160 (C-O), 768 (ArH); 1H NMR (300 MHz; 
CDCl3; Me4Si): δH (ppm) = 1.24 (9H, s, 3×CH3), 6.60 (1H, s, 3-H), 7.26-7.47 
(3H, m, 3×ArH), 7.51-7.66 (3H, m, 3×ArH), 8.01 (1H, d, J=7.7 Hz, ArH), 8.28 
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(1H, d, J=8.3 Hz, ArH), 10.01 (1H, s, CHO); 13C NMR (75 MHz, CDCl3): δC 
(ppm) = 27.5 (3×CH3), 83.9 [(CH3)3C], 112.6 (3-C), 115.7 (ArCH), 120.6 
(ArCH), 123.3 (ArCH), 124.9 (ArCH), 127.3 (ArCH), 128.5 (ArCH), 128.8 
(ArC), 131.0 (ArCH), 133.1 (ArCH), 134.9 (ArC), 135.2 (ArC), 137.0 (ArC), 
138.3 (ArC), 149.7 (NC=O), 191.6 (PhC=O); MS: m/z (EI): 321 (M+, 16 %), 
221 (24), 193 (100), 165 (17), 57 (53), 41 (13); HRMS: C20H19NO3 requires: 
321.1365, found: 321.1323. 
 
4.2.1.4. Attempted Synthesis of 2-(1H-Indol-2-yl)benzaldehyde 193 
 
193
N
H
O
 
 
Method 1:85 
 
tert-Butyl 2-(2-formylphenyl)-1H-indole-1-carboxylate (0.50 g, 1.6 mmol)  191 
was absorbed onto silica  in a 100 cm3 round bottom flask by mixing silica and 
ethyl acetate and then evaporating the mixture to dryness on a rotary 
evaporator. The flask was then placed in the microwave and exposed to 
irradiation at 150 W for 13 min at 30 s intervals. The resulting mixture was 
purified by column chromatography (10% ethyl acetate/hexane) to afford 
starting material (0.15 g, 30%) and unidentifiable material. 
 
Method 2:86 
 
tert-Butyl 2-(2-formylphenyl)-1H-indole-1-carboxylate (1.45 g, 4.51 mmol) 191 
was dissolved in dichloromethane (70 cm3) in a 100 cm3 round bottom flask. 
The solution was lowered to 0 ºC and aluminum trichloride (0.78 g, 5.9 mmol, 
1.3 equiv.) was added. After stirring for 1 h, water was added and the organic 
material was extracted with dichloromethane (3 × 70 cm3). The organic layers 
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were combined, dried with anhydrous magnesium sulfate and the solvent 
removed in vacuo. The residue obtained was purified by column 
chromatography (10% ethyl acetate/ hexane) to afford only unidentifiable 
material.    
 
4.2.1.5. Synthesis of tert-Butyl 2-(2-acetylphenyl)-1H-indole-1-
carboxylate 19283 
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Triphenylphosphine palladium (0) (0.53 g, 0.46 mmol, 10 mol %) was added 
to a 50 cm3 flame dried, round bottom flask, equipped with a condenser and 
dropping funnel. The boronic acid 190 (1.80 g, 6.89 mmol, 1.5 equiv.), 1-(2-
bromophenyl)ethanone (0.92 g, 4.6 mmol) 200 and DME (12.7 cm3, 1.1% of 
Na2CO3 solution) were combined in the dropping funnel and degassed before 
adding to the flask. A 2M Na2CO3 solution (2.44 g, 23.0 mmol, 5 equiv.) was 
added to the dropping funnel, degassed and then added to the flask. The 
dropping funnel was closed and the resulting mixture was degassed once 
more before heating at reflux for 72 h. Water (50 cm3) was added and the 
solution was extracted with ethyl acetate (3 × 50 cm3). The organic layers 
were combined and dried with anhydrous magnesium sulfate. The solvent 
was removed in vacuo and the residue was purified by column 
chromatography (2% ethyl acetate/hexane) to afford tert-butyl 2-(2-
acetylphenyl)-1H-indole-1-carboxylate 192 as an orange-pink viscous oil that 
eventually solidified (0.97 g, 63%). Rf = 0.23 (10% ethyl acetate/hexane); m.p. 
91-92 ºC; νmax (film)/cm-1: 2980 (ArC-H), 1731 and 1688 (C=O), 1598 
(ArC=C), 1161 (C-O), 746 (ArH); 1H NMR (300 MHz; CDCl3; Me4Si): δH (ppm) 
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= 1.29 (9H, s, 3×CH3), 2.33 (3H, s, CH3C=O), 6.48 (1H, s, 3-H), 7.22-7.55 
(6H, m, 6×ArH), 7.73 (1H, d, J=7.4 Hz, ArH), 8.24 (1H, d, J=8.3 Hz, ArH); 13C 
NMR (75 MHz, CDCl3): δC (ppm) = 27.4 (3×CH3), 28.6 (CH3C=O), 83.2 
[(CH3)3C], 110.3 (3-C), 115.5 (ArCH), 120.3 (ArCH), 122.8 (ArCH), 124.3 
(ArCH), 127.9 (ArCH), 128.0 (ArCH), 129.0 (ArC), 130.6 (ArCH), 130.8 
(ArCH), 133.7 (ArC), 136.6 (ArC), 138.2 (ArC), 139.0 (ArC), 149.6 (NC=O), 
200.8 (PhC=O); MS: m/z (EI): 335 (M+, 30 %), 235 (100), 220 (65), 165 (13), 
57 (58), 41 (16), 30 (12); HRMS: C21H21NO3 requires: 335.1521, found: 
335.1530. 
 
4.2.1.6. Synthesis of 1-(2-(1H-Indole-2-yl)phenyl)ethanone 194 
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Method 1:87 
 
tert-Butyl 2-(2-acetylphenyl)-1H-indole-1-carboxylate 192 (0.20 g, 0.60 mmol) 
was dissolved in dichloromethane (20 cm3) in a 50 cm3 round bottom flask. 
Trifluoroacetic acid (0.07 cm3, 0.9 mmol, 1.5 equiv.) was added and the 
solution went from clear to light yellow. The solution was stirred at room 
temperature for 6 h before it was treated with NaHCO3 and then extracted 
with dichloromethane (3 × 20 cm3). The organic layers were combined, 
washed with brine and dried with anhydrous MgSO4. The solvent was 
removed in vacuo to afford a yellow residue that contained a variety of 
unidentifiable products. 
 
Method 2:88 
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tert-Butyl 2-(2-acetylphenyl)-1H-indole-1-carboxylate 192 (0.20 g, 0.60 mmol) 
was dissolved in THF (0.60 cm3) in a 50 cm3 round bottom flask. A 6.5 M 
solution of NaOMe in methanol (0.28 cm3, 1.8 mmol, 3 equiv.) was added and 
the resulting mixture was stirred at room temperature for 30 min. The reaction 
mixture was worked up using 0.1 M HCl (5 cm3) and extracted with ether (3 × 
5 cm3). The organic layers were combined, dried with anhydrous MgSO4 and 
the solvent was removed in vacuo. The yellow residue obtained was purified 
by column chromatography (10% ethyl acetate/hexane) to afford 1-(2-(1H-
indole-2-yl)phenyl)ethanone 194 as a whitish yellow solid (0.090 g, 64%). Rf = 
0.32 (10% ethyl acetate/hexane); m.p. ; 1H NMR (300 MHz; CDCl3; Me4Si): δH 
(ppm) = 1.95 (3H, s, CH3C=O), 2.77 (1H, bs, NH), 6.53 (1H, s, 3-H), 7.08 (1H, 
t, J=7.5 Hz, ArH), 7.16-7.23 (1H, m, ArH), 7.29 (1H, t, J=7.5 Hz, ArH), 7.38 
(1H, t, J=7.4 Hz, ArH), 7.48 (1H, d, J= 7.4 Hz, ArH), 7.55-7.60 (3H, m, 3×ArH); 
13C NMR (75 MHz, CDCl3): δC (ppm) = 24.9 (CH3C=O), 89.0 (ArC), 93.3 (3-
C), 110.5 (ArCH), 120.0 (ArCH), 120.7 (ArCH), 121.7 (ArCH), 122.4 (ArCH), 
122.7 (ArCH), 127.8 (ArCH), 129.6 (ArCH), 130.9 (ArC), 133.0 (ArC), 133.6 
(ArC), 139.9 (ArC), 198.8 (PhC=O); 
 
4.2.1.7. Attempted Synthesis of 1-(2-(1-Benzyl-1H-indol-2-yl)phenyl)- 
ethanoate 196 
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N
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At –20 ºC, NaH (0.013 g, 0.18 mmol, 1 equiv.) was added to a solution of 1-
(2-(1-benzyl-1H-indol-2-yl)phenyl)ethanoate 194 (0.060 g, 0.18 mmol) in THF 
(5 cm3). The solution was warmed up to room temperature and stirred for 3h 
before benzyl bromide (0.02 cm3, 0.2 mmol, 1 equiv.) was added drop wise. 
The resulting mixture was stirred for 72 h. Dichloromethane (5 cm3) was 
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added and the solution was washed with water (3 × 5 cm3). The organic layer 
was dried with anhydrous MgSO4 and the solvent was removed in vacuo to 
afford a yellow residue. The residue was purified by column chromatography 
(5% ethyl acetate/hexane) to afford 3 unidentifiable products. 
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4.2.2. Experimental Procedures for the Alternative route to the Synthesis 
of 6-Phenylindolo[2,1-a]-isoquinoline 179 
 
4.2.2.1. Attempted Synthesis of 1-Benzylindolin-2-one 20691 
 
206
N
O
 
 
Method 1: 
 
Oxindole 203 (0.25 g, 1.9 mmol) was dissolved in THF (25.0 cm3) before 
adding NaH (0.094g, 2.1 mmol, 1.1 equiv.) at room temperature. Benzyl 
bromide (0.24 cm3, 2.0 mmol, 1.1 equiv.) was added and the mixture was 
stirred for 24 h. Dichloromethane (25 cm3) was added and the solution was 
washed with water (3 × 25 cm3). The organic layer was dried with anhydrous 
MgSO4 and the solvent was removed in vacuo to afford a pinkish brown 
residue. The residue was purified by column chromatography (5→10→20% 
ethyl acetate/hexane) to afford 3 unidentifiable products. 
 
Method 2: 
 
Oxindole 203 (0.25 g, 1.9 mmol) was dissolved in DMF (20.09 cm3) in a 50 
cm3 round bottom flask. The solution was lowered to 0 ºC and NaH (0.094 g, 
2.1 mmol, 1.1 equiv.) was added. The resulting mixture was stirred at 0 ºC for 
30 min. and then warmed up to room temperature. The solution was stirred for 
a further 1 h before benzyl bromide (0.24 cm3, 2.0 mmol, 1.05 equiv.) was 
added drop wise. After stirring for a long period of time, the reaction was 
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eventually aborted, as TLC (30% ethyl acetate/hexane) only detected base 
line material. 
 
Method 3: 
 
A mixture of oxindole 203 (0.25 g, 1.9 mmol), potassium carbonate (0.26 g, 
1.9 mmol, 1 equiv.) and benzyl bromide (0.27 cm3, 2.3 mmol, 1.2 equiv.) were 
dissolved in DMF (1.50 cm3) in a 10 cm3 beaker. The resulting mixture was 
exposed to microwave radiation (150 W) for 2 min. at 10 sec. intervals. The 
solution was allowed to cool and water (5 cm3) was added. The resulting 
orange precipitate was filtered off, dried in vacuo and purified by column 
chromatography (10% ethyl acetate/hexane) to afford 3 unidentifiable 
products. 
 
4.2.2.2. Synthesis of 1-Benzylindoline-2,3-dione 20890 
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Method 1: 
 
A mixture of isatin 182 (2.21 g, 15.0 mmol), potassium carbonate (3.00 g, 15.0 
mmol, 1 equiv.) and benzyl bromide (5.34 cm3, 45.0 mmol, 3 equiv.) were 
dissolved in DMF (9.00 cm3) in a 100 cm3 beaker. The resulting mixture was 
exposed to microwave radiation (150 W) for 2 min. at 30 sec. intervals. The 
solution was allowed to cool and water (50 cm3) was added. The resulting 
orange precipitate was filtered off and washed with water. The crude product 
was recrystallised from ethanol to afford 1-benzylindoline-2,3-dione 208 as 
orange needle-like crystals (2.00 g, 88%). Rf = 0.42 (30% ethyl 
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acetate/hexane); m.p. 133-134 ºC; 1H NMR (300 MHz; CDCl3; Me4Si): δH 
(ppm) = 4.94 (2H, s, CH2), 6.78 (1H, d, J=7.9 Hz, ArH), 7.09 (1H, t, J=7.6 Hz, 
ArH), 7.25-7.38 (5H, m, 5×ArH), 7.48 (1H, dt, J=1.2 and 7.8Hz, ArH), 7.61 
(1H, d, J=7.5Hz, ArH); 13C NMR (75 MHz, CDCl3): δC (ppm) = 44.0 (CH2), 
110.0 (ArCH), 117.6 (ArC), 123.8 (ArCH), 125.3 (ArCH), 127.4 (2×ArCH), 
128.1 (ArCH), 129.0 (2×ArCH), 134.5 (ArC), 138.3 (ArCH), 150.7 (ArC), 158.2 
(2-C), 183.2 (3-C).  
 
Method 2: 
 
Isatin 182 (8.00 g, 54.0 mmol) and CaH2 (2.29 g, 54.0 mmol, 1 equiv.) were 
dissolved in DMF (27.0 cm3) in a 50 cm3 round bottom flask. The solution was 
stirred at 100 ºC for 1 h and then cooled to 40 ºC so that benzyl bromide (7.10 
cm3, 60.0 mmol, 1.1 equiv.) could be added slowly. The resulting mixture was 
heated to 100 ºC for 4 h and then allowed to cool to room temperature. The 
solution was poured into a 0.5 M HCl solution (200 cm3), with vigorous stirring, 
which resulted in an orange precipitate. The precipitate was filtered off and 
washed with water. The crude product was further purified by recrystalisation 
with dichloromethane layered with hexane to afford 1-benzylindoline-2,3-dione 
208 as orange needle-like crystals (11.44 g, 89%). 
 
4.2.2.3. Synthesis of 1-Benzyl-3,3-dichloroindolin-2-one 209 
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The dione 208 (6.40 g, 27.0 mmol) was dissolved in benzene (70 cm3) in a 
100 cm3 round bottom flask. Phosphorus pentachloride (12.80 g, 62.10 mmol, 
2.3 equiv.) was added and the solution was warmed to 25 ºC for 24 h. The 
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solvent was removed in vacuo to obtain a yellow brown residue, which was 
further purified by column chromatography (5% ethyl acetate/hexane) to 
afford 1-benzyl-3,3-dichloroindolin-2-one 209 as a light yellow oil. On addition 
of ethanol the chlorinated product 209 precipitated out as a white solid (6.37g, 
81%). Rf = 0.58 (30% ethyl acetate/hexane); m.p. 125-126 ºC; 1H NMR (300 
MHz; CDCl3; Me4Si): δH (ppm) = 4.94 (2H, s, CH2), 6.72 (1H, d, J=7.9 Hz, 
ArH), 7.14 (1H, t, J=7.6 Hz, ArH), 7.22-7.39 (6H, m, 6×ArH), 7.64 (1H, d, 
J=7.5Hz, ArH); 13C NMR (75 MHz, CDCl3): δC (ppm) = 44.5 (CH2), 110.1 (3-
C), 124.2 (ArCH), 124.9 (ArCH), 127.1 (2×ArCH), 128.1 (ArCH), 129.0 
(2×ArCH), 129.3 (ArC), 131.8 (ArCH), 134.4 (ArC), 139.8 (ArC), 169.2 (2-C).  
 
4.2.2.4. Synthesis of 1-Benzylindolin-2-one 206 
 
206
1
2
34
5
6 N
7
O
 
 
Method 1: 
 
In a 10 cm3 round bottom flask, 1-benzyl-3,3-dichloroindolin-2-one 209 (0.20 
g, 0.68 mmol) was dissolved in acetic acid (5 cm3). Adams catalyst (PtO2, 
0.02 g, 10 mol %) was added and the solution was degassed before exposing 
it to a hydrogen atmosphere for 6 h. The catalyst was filtered off and most of 
the acetic acid was removed in vacuo. A concentrated NaHCO3 solution was 
added until effervescence stopped and the solution was extracted with 
dichloromethane (3 × 10 cm3). The organic layers were combined, dried with 
anhydrous MgSO4 and the solvent removed in vacuo. The resulting residue 
was purified by column chromatography (20% ethyl acetate/hexane) to afford 
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1-benzylindolin-2-one 206 as a light yellow oil that eventually solidified into a 
white solid (0.12 g, 79%) (38-48% yield and recovered starting material).  
Method 2: 
 
In a 250 cm3 round bottom flask, 1-benzyl-3,3-dichloroindolin-2-one 209 (3.00 
g, 10.3 mmol) was dissolved in acetic acid (90 cm3). Activated zinc (10.00 g, 
154.5 mmol, 15 equiv.) was added over a 10 min. period and the resulting 
mixture was stirred for a further 10 min, at room temperature. The zinc was 
filtered off and washed with acetic acid and ethyl acetate. Most of the solvent 
was removed in vacuo and concentrated NaHCO3 was added until 
effervescence stopped. The solution was extracted with diethylether (3 × 50 
cm3), the organic layers combined and the solvent dried with anhydrous 
MgSO4. The solvent was removed in vacuo and the resulting residue was 
purified by column chromatography (20% ethyl acetate/hexane) to afford 1-
benzylindolin-2-one 206 as a white solid (1.75 g, 76%); Rf = 0.40 (30% ethyl 
acetate/hexane); m.p. 60-62 ºC; 1H NMR (300 MHz; CDCl3; Me4Si): δH (ppm) 
= 3.62 (2H, s, 3-H), 4.91 (2H, s, CH2), 6.72 (1H, d, J=7.8 Hz, ArH), 7.00 (1H, t, 
J=7.5 Hz, ArH), 7.16 (1H, t, J=7.8 Hz, ArH), 7.21-7.34 (6H, m, 6×ArH); 13C 
NMR (75 MHz, CDCl3): δC (ppm) = 35.7 (3-C), 43.7 (CH2), 109.0 (ArCH), 
122.3 (ArCH), 124.3 (ArCH), 124.4 (ArC), 127.3 (2×ArCH), 127.6 (ArCH), 
127.8 (ArCH), 128.7 (2×ArCH), 135.9 (ArC), 144.3 (ArC), 175.1 (2-C).    
 
 
4.2.2.5. Synthesis of 1-Benzyl-2-bromo-1H-indole 20190,96 
 
1
2
34
5
6 N
7
Br
201  
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Method 1 
 
Phosphorus oxybromide (0.19 g, 0.68 mmol, 1.5 equiv.) was added to a 
solution of 1-benzylindolin-2-one 206 (0.10 g, 0.45 mmol) in dichloromethane 
(10.00 cm3). The resulting mixture was stirred at reflux for 1 h. The solution 
was cooled to room temperature and imidazole (0.04 g, 0.5 mmol, 1.2 equiv.) 
was added before refluxing for a further 48 h. A 2M NaHCO3 solution was 
added until effervescence stopped and the solution was extracted with 
dicholoromethane (3 × 30 cm3). The organic layers were combined, washed 
with brine and dried with anhydrous MgSO4 before removing the solvent in 
vacuo. The resulting orange residue was purified by column chromatography 
(2% ethyl acetate/hexane) to afford the brominated compound 201 as a white 
solid (0.07 g, 88%) and starting material (0.02 g, 20%); m.p. 87-89 ºC; νmax 
(film)/cm-1: 3000 (ArC-H), 1605 (ArC=C), 780 (ArH), 691 (C-Br); 1H NMR 
(300 MHz; CDCl3; Me4Si): δH (ppm) = 5.41 (2H, s, CH2), 6.65 (1H, s, 3-H), 
7.06-7.13 (4H, m, 4×ArH), 7.20-7.28 (4H, m, 4×ArH), 7.55 (1H, dd, J=2.2 and 
6.4 Hz, ArH); 13C NMR (75 MHz, CDCl3): δC (ppm) = 48.1 (CH2), 104.5 (3-C), 
109.0 (ArCH), 113.5 (ArC), 119.8 (ArCH), 120.3 (ArCH), 122.0 (ArCH), 126.4 
(2×ArCH), 127.5 (ArCH), 128.2 (ArC), 128.7 (2×ArCH), 136.7 (ArC), 137.0 
(ArC); MS: m/z (EI): 285 (M+, 42 %), 204 (11), 91 (100), 65 (9); HRMS: 
C15H12N79Br requires: 285.0153, found: 285.0091. 
   
Method 2 
 
Phosphorus oxybromide (0.16 g, 0.54 mmol, 1.2 equiv.) was added to a 
solution of 1-benzylindolin-2-one 206 (0.10 g, 0.45 mmol) in dichloromethane 
(10.0 cm3). The resulting mixture was stirred at reflux for 72 h. A 2M NaHCO3 
solution was added until effervescence stopped and the solution was 
extracted with dicholoromethane (3 × 30 cm3). The organic layers were 
combined, washed with brine and dried with anhydrous MgSO4 before 
removing the solvent in vacuo. The resulting residue was purified by column 
chromatography (2% ethyl acetate/hexane) to afford the brominated 
compound 201 as a white solid (0.07 g, 55%). 
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Method 3 
 
Phosphorus oxybromide (0.19 g, 0.64 mmol, 1.5 eq) was added to a solution 
of 1-benzylindolin-2-one 206 (0.10 g, 0.45 mmol) in dichloroethane (5.0 cm3). 
The resulting mixture was stirred at reflux for 24 h. A 2M NaHCO3 solution 
was added until effervescence stopped and the solution was extracted with 
dicholoromethane (3 × 30 cm3). The organic layers were combined, washed 
with brine and dried with anhydrous MgSO4 before removing the solvent in 
vacuo. The resulting residue was purified by column chromatography (2% 
ethyl acetate/hexane) to afford 2 uncharacterizable compounds. 
 
Method 4 
 
Phosphorus oxybromide (0.19 g, 0.68 mmol, 1.5 equiv.) was added to a 
solution of 1-benzylindolin-2-one 206 (0.10 g, 0.45 mmol) in dichloroethane 
(5.0 cm3). The resulting mixture was stirred at reflux for 1 h. The solution was 
cooled to room temperature and imidazole (0.04 g, 0.5 mmol, 1.2 equiv.) was 
added before refluxing for a further 48 h. A 2M NaHCO3 solution was added 
until effervescence stopped and the solution was extracted with 
dicholoromethane (3 × 30 cm3). The organic layers were combined, washed 
with brine and dried with anhydrous MgSO4 before removing the solvent in 
vacuo. The resulting residue was purified by column chromatography (2% 
ethyl acetate/hexane) to afford uncharacterizable material. 
 
Method 5 
 
Phosphorus bromide (0.05 cm3, 0.6 mmol, 1.2 equiv.) was added to a solution 
of 1-benzylindolin-2-one 206 (0.10 g, 0.45 mmol) in CH3CN (5.0 cm3). The 
resulting mixture was stirred at reflux for 72 h. A 2M NaHCO3 solution was 
added until effervescence stopped and the solution was extracted with 
dicholoromethane (3 × 30 cm3). The organic layers were combined, washed 
with brine and dried with anhydrous MgSO4 before removing the solvent in 
vacuo. The resulting residue was purified by column chromatography (2% 
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ethyl acetate/hexane) to afford the brominated compound 201 as a white solid 
(0.09 g, 7%) and 4 uncharacterizable compounds. 
 
   
4.2.2.6. Synthesis of 2-(1-Benzyl-1H-indol-2-yl)benzaldehyde 19583 
 
195
1
2
34
5
6
N
7
O
 
 
Tetrakis(triphenylphosphine)palladium(0) (0.10 g, 0.087 mmol, 10 mol %) was 
added to a 50 cm3 flame dried, round bottom flask, equipped with a 
condenser and dropping funnel. The bromide 201 (0.25 g, 0.87 mmol), 2-
formylphenylboronic acid 185 (0.15 g, 1.3 mmol, 1.5 equiv.) and DME (2.4 
cm3, 1.1% of Na2CO3 solution) were combined in the dropping funnel and 
degassed before adding to the flask. A 2M Na2CO3 solution (0.46 g, 4.4 mmol, 
5 equiv.) was added to the dropping funnel, degassed and then added to the 
flask. The dropping funnel was closed and the resulting mixture was 
degassed once more before refluxing for 24 h. Water (10 cm3) was added and 
the solution was extracted with ethyl acetate (3 × 20 cm3). The organic layers 
were combined and dried with anhydrous magnesium sulfate. The solvent 
was removed in vacuo and the residue was purified by silica gel column 
chromatography (2% ethyl acetate/hexane) to afford 2-(1-benzyl-1H-indol-2-
yl)benzaldehyde 195 as a yellow, viscous oil (0.25 g, 92%). Rf = 0.74 (30% 
ethyl acetate/hexane); νmax (film)/cm-1: 3060 (ArC-H), 1710 (C=O), 1550 
(ArC=C), 750 (ArH); 1H NMR (300 MHz; CDCl3; Me4Si): δH (ppm) = 5.26 (2H, 
s, CH2), 6.63 (1H, s, 3-H), 6.83 (2H, dd, J=3.9 and 5.3 Hz, 2×ArH), 7.16-7.27 
(5H, m, 5×ArH), 7.32 (1H, d, J=8.0 Hz, ArH), 7.40 (1H, dd, J=1.2 and 7.4 Hz, 
ArH), 7.50-7.61 (2H, m, 2×ArH), 7.69 (1H, dd, J=1.1 and 6.9Hz, ArH), 8.01 
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(1H, dd, J=1.4 and 7.6 Hz, ArH), 9.85 (1H, s, CHO); 13C NMR (75 MHz, 
CDCl3): δC (ppm) = 47.6 (CH2), 106.8 (3-C), 110.4 (ArCH), 120.5 (ArCH), 
120.8 (ArCH), 122.7 (ArCH), 126.1 (2×ArCH), 127.4 (ArCH), 127.5 (ArCH), 
127.9 (ArC), 128.7 (2×ArCH), 129.0 (ArCH), 131.4 (ArCH), 133.2 (ArCH), 
135.4 (ArC), 135.5 (ArC), 135.8 (ArC), 137.4 (ArC), 137.8 (ArC), 191.6 (C=O);  
MS: m/z (EI): 311 (M+, 33 %), 283 (58), 282 (65), 221 (19), 220 (100), 206 
(39), 182 (53), 181 (72), 180 (20), 153 (20), 152 (30), 91 (87), 86 (27), 84 
(41), 76 (15), 57 (22), 43 (18); HRMS: C22H17NO requires: 311.1310, found: 
311.1335. 
 
 
4.2.2.7. Synthesis of 5,6-Dihydro-6-phenylindolo[2,1-a]isoquinolin-5-ol 
216 and 21777 
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To a solution of 2-(1-benzyl-1H-indol-2-yl)benzaldehyde 195 (0.20 g, 0.64 
mmol) in DMF (20 cm3) was added tBuOK (0.086 g, 0.77 mmol, 1.2 equiv.) 
and the resulting mixture was stirred for 2 min. at room temperature. The 
solution was quenched with H2O (40 cm3) and the organic layer was extracted 
with ether (3 × 40 cm3). After the organic layers were combined and dried, the 
solvent was removed in vacuo. The residue obtained was purified by column 
chromatography (2→5% ethyl acetate/ hexane) to afford the anti- and syn-
diastereomers 216 and 217 as yellow-green resins in a 7:3 ratio (53% anti 
and 22% syn). Rf (syn) 216 = 0.49 (30% ethyl acetate/hexane); νmax 
(film)/cm-1: 3548 (NH), 3423 (OH), 3060 (ArC-H), 1605 (ArC=C), 747 (ArH); 
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1H NMR (300 MHz; CDCl3; Me4Si): δH (ppm) = 1.66 (1H, d, J= 11.0 Hz, OH), 
5.38 (1H, dd, J=7.0 Hz and 11.0 Hz, CH-OH), 5.71 (1H, d, J=6.9 Hz, NCH), 
6.84 (2H, m, 2×ArH), 6.92 (1H, s, ArH), 6.97-7.05 (5H, m, 5×ArH), 7.11-7.21 
(2H, m, 2×ArH), 7.29 (1H, t, J=7.4 Hz, ArH), 7.38 (1H, d, J = 7.8 Hz, ArH), 
7.54 (1H, dd, J=2.2 and 6.4Hz, ArH), 7.75 (1H, d, J = 7.6 Hz, ArH); 13C NMR 
(75 MHz, CDCl3): δC (ppm) = 59.5 (COH), 69.5 (NCH), 97.4 (ArCH), 109.4 
(ArCH), 120.5 (ArCH), 120.8 (ArCH), 122.3 (ArCH), 123.9 (ArCH), 125.0 
(ArCH), 127.3 (ArC), 127.9 (2×ArCH), 128.0 (ArCH), 128.1 (ArCH), 128.4 
(ArCH), 128.6 (2×ArCH), 129.1 (ArC), 133.4 (ArC), 134.5 (ArC), 135.0 (ArC), 
136.4 (ArC); MS: m/z (EI): 311 (M+, 100 %), 310 (18), 283 (17), 282 (47), 280 
(14), 234 (17), 220 (42), 206 (41), 204 (30), 178 (15), 165 (18), 155 (14), 91 
(20); HRMS: C22H17NO requires: 311.1310, found: 311.1302. 
 
Rf (anti) 217 = 0.36 (30% ethyl acetate/hexane); νmax (film)/cm-1: 3364 (OH), 
3058 (ArC-H), 1607 (ArC=C), 747 (ArH); 1H NMR (300 MHz; CDCl3; Me4Si): 
δH (ppm) = 2.18 (1H, bs, OH), 4.91 (1H, s, CH-OH), 5.81 (1H, d, J=1.5 Hz, 
NCH), 6.70 (2H, dd, J=2.6 and 6.6 Hz, 2×ArH), 6.97 (1H, s, ArH), 7.00-7.09 
(5H, m, 5×ArH), 7.12-7.18 (3H, m, 3×ArH), 7.29-7.35 (1H, m, ArH), 7.58-7.60 
(1H, m, ArH), 7.79 (1H, d, J=7.7 Hz, ArH); 13C NMR (75 MHz, CDCl3): δC 
(ppm) = 62.0 (COH), 73.9 (NCH), 97.6 (ArCH), 109.6 (ArCH), 120.5 (ArCH), 
120.9 (ArCH), 122.4 (ArCH), 124.4 (ArCH), 125.9 (2×ArCH), 127.7 (ArCH), 
128.0 (ArC), 128.1 (ArCH), 128.7 (2×ArCH), 129.1 (ArC), 129.7 (ArCH), 129.9 
(ArCH), 131.0 (ArC), 133.7 (ArC), 137.4 (ArC), 137.8 (ArC); MS: m/z (EI): 311 
(M+, 100 %), 310 (20), 283 (18), 282 (47), 280 (14), 234 (18), 220 (42), 217 
(14), 206 (42), 204 (31), 178 (16), 165 (19), 155 (15), 91 (21); HRMS: 
C22H17NO requires: 311.1310, found: 311.1339. 
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4.2.2.8. Attempted Synthesis of 6-Phenylindolo[2,1-a]isoquinoline 1794 
 
179
N
 
 
To a solution of 5,6-dihydro-6-phenylindolo[2,1-a]isoquinolin-5-ol 222 (0.15 g, 
0.48 mmol) in CH2Cl2 (50.0 cm3) was added 21 activated pieces of molecular 
sieves followed by pTSA (0.02 g, 72 mmol, 15 mol %). The reaction mixture 
was stirred for 24 h at room temperature before a further 15 mol % of pTSA 
was added and the solution stirred at reflux for another 24 h. At this time TLC 
indicated that only about 3% of the diastereomeric mixture had converted into 
another compound. Concentrated H2SO4 (10 drops over 5 h) was added to 
the reaction mixture and the solution was stirred at reflux for 15 h, at which 
point TLC indicated that the reaction mixture had decomposed. 
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4.2.2. Experimental Procedures for the Synthesis of Ethyl 
Indolo[2,1-a]isoquinoline-6-carboxylate 183 Using the 
Alternative Route 
 
 
4.2.3.1. Synthesis of Ethyl 2-(2,3-dioxoindolin-1-yl)acetate 21894 
 
218
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Small Scale: 
 
Isatin 182 (0.44 g, 0.30 mmol) and CaH2 (0.42 g, 10 mmol, 3.3 equiv.) were 
dissolved in DMF (5.0 cm3) in a 20 cm3 round bottom flask. The solution was 
stirred at 45 ºC for 0.5hand then cooled to room temperature so that ethyl 2-
bromoacetate (1.00 cm3, 9.00 mmol, 3 equiv.) could be added slowly. The 
resulting mixture was warmed to 45 ºC for a further 24 h. The solution was 
cool to room temperature and neutralized with an aqueous 1 M HCl solution. 
The organic layer was extracted with ether (3 × 20 cm3), the organic layers 
were combined and dried with anhydrous MgSO4. The solvent was removed 
in vacuo and the residue obtained was purified by column chromatography 
(hexane→2%→5% ethyl acetate/hexane) to afford ethyl 2-(2,3-dioxoindolin-1-
yl)acetate 218 as a bright, yellow solid (0.58 g, 83%). Rf = 0.24 (30% ethyl 
acetate/hexane); m.p. 132-133 ºC; νmax (film)/cm-1: 2983 (ArC-H), 1740 
(C=O), 1615 (ArC=C), 1210 (C-O), 757 (ArH); 1H NMR (300 MHz; CDCl3; 
Me4Si): δH (ppm) = 1.29 (3H, t, J=7.1 Hz, CH3), 4.25 (2H, q, J=7.1 Hz, OCH2) 
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4.49 (2H, s, NCH2), 6.79 (1H, d, J=7.9 Hz, ArH), 7.16 (1H, t, J=7.5 Hz, ArH), 
7.57-7.62 (1H, dt, J=1.2 and 7.8 Hz, ArH), 7.66 (1H, d, J=7.5 Hz, ArH); 13C 
NMR (75 MHz, CDCl3): δC (ppm) = 14.1 (CH3), 41.3 (NCH2), 62.2 (OCH2), 
110.1 (ArCH), 117.7 (ArC), 124.1 (ArCH), 125.6 (ArCH), 138.4 (ArCH), 150.3 
(ArC), 158.0 (2-C), 166.7 (CO2Et), 182.4 (3-C); MS: m/z (EI): 233 (M+, 35 %), 
132 (100), 77 (24), 51 (9); HRMS: C12H11NO4 requires: 233.0688, found: 
233.0675. 
 
 
Large Scale: 
 
Isatin 182 (10.00 g, 68.00 mmol) and CaH2 (2.86 g, 68.0 mmol, 1 equiv.) were 
dissolved in DMF (35.0 cm3) in a 50 cm3 round bottom flask. The solution was 
stirred at 100 ºC for 1hand then cooled to 40 ºC so that ethyl 2-bromoacetate 
(22.62 cm3, 204.0 mmol, 3 equiv.) could be added slowly. The resulting 
mixture was heated to 100 ºC for 4 h and then allowed to cool to room 
temperature. The solution was poured into a 0.5 M HCl solution (200 cm3), 
with vigorous stirring, which resulted in a yellow precipitate. The precipitate 
was filtered off and washed with water. The crude product was further purified 
by recrystalisation with hexane layered dichloromethane to afford ethyl 2-(2,3-
dioxoindolin-1-yl)acetate 218 as yellow crystals in quantitative yield. 
 
4.2.3.2. Synthesis of ethyl 2-(3,3-dichloro-2-oxoindolin-1-yl)acetate 21990 
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The dione 218 (2.50 g, 10.7 mmol) was dissolved in benzene (40 cm3) in a 
100 cm3 round bottom flask. Phosphorus pentachloride (5.00 g, 24.6 mmol, 
2.3 equiv.) was added and the solution was warmed to 25 ºC for 24 h. The 
solvent was removed in vacuo to obtain a light, yellow residue, which was 
further purified by column chromatography (hexane→2% ethyl 
acetate/hexane) to afford ethyl 2-(3,3-dichloro-2-oxoindolin-1-yl)acetate 219 
as a white solid (3.10 g, 100%). Rf = 0.43 (30% ethyl acetate/hexane); m.p. 
115-116 ºC; νmax (film)/cm-1: 2984 (ArC-H), 1746 (C=O), 1613 (ArC=C), 1102 
(C-O), 752 (ArH), 670 (C-Cl); 1H NMR (300 MHz; CDCl3; Me4Si): δH (ppm) = 
1.26 (3H, t, J=7.1 Hz, CH3), 4.23 (2H, q, J=7.1 Hz, OCH2) 4.48 (2H, s, NCH2), 
6.77 (1H, d, J=7.9 Hz, ArH), 7.19 (1H, t, J=7.7 Hz, ArH), 7.39 (1H, dt, J=1.0 
and 7.8 Hz, ArH), 7.66 (1H, d, J=7.5 Hz, ArH); 13C NMR (75 MHz, CDCl3): δC 
(ppm) = 14.0 (CH3), 41.8 (NCH2), 62.1 (OCH2), 73.9 (ArCH), 109.1 (ArCH), 
124.5 (ArCH), 125.0 (ArCH), 129.0 (ArC), 131.8 (ArCH), 139.4 (ArC), 166.4 
(2-C), 168.9 (CO2Et); MS: m/z (EI): 287 (M+, 39 %), 254 (37), 252 (100), 216 
(23), 214 (36), 188 (11), 186 (18), 173 (23), 151 (21), 89 (18); HRMS: 
C12H11NO35Cl2 requires: 287.0116, found: 287.0151. 
 
 
4.2.3.3. Synthesis of Ethyl 2-(2-oxoindolin-1-yl)acetate 220 
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In a 20 cm3 round bottom flask, ethyl 2-(3,3-dichloro-2-oxoindolin-1-yl)acetate 
219 (0.15 g, 0.52 mmol) was dissolved in acetic acid (5 cm3). Activated zinc 
(0.50 g, 7.3 mmol, 14 equiv.) was added over a 10 min. period and the 
 110
resulting mixture was stirred for a further 5 min, at room temperature. The zinc 
was filtered off and washed with acetic acid and ethyl acetate. Most of the 
solvent was removed in vacuo and concentrated NaHCO3 was added until 
effervescence stopped. The solution was extracted with ether (3 × 20 cm3), 
the organic layers combined and the solvent dried with anhydrous MgSO4. 
The solvent was removed in vacuo and the resulting residue was purified by 
column chromatography (2%→5% ethyl acetate/hexane) to afford ethyl 2-(2-
oxoindolin-1-yl)acetate 220 as a white solid in quantitative yield; Rf = 0.09 
(30% ethyl acetate/hexane); m.p. 127-129 ºC; νmax (film)/cm-1: 2985 (ArC-H), 
1740 and 1715 (C=O), 1615 (ArC=C), 1114 (C-O), 757 (ArH); 1H NMR (300 
MHz; CDCl3; Me4Si): δH (ppm) = 1.27 (3H, t, J=7.1 Hz, CH3), 3.60 (2H, s, 3-
H), 4.22 (2H, q, J=7.1 Hz, OCH2) 4.47 (2H, s, NCH2), 6.70 (1H, d, J=7.8 Hz, 
ArH), 7.05 (1H, t, J=7.5 Hz, ArH), 7.23-7.28 (2H, m, 2×ArH); 13C NMR (75 
MHz, CDCl3): δC (ppm) = 14.1 (CH3), 35.5 (ArCH2), 41.3 (NCH), 61.7 (OCH2), 
108.1 (ArCH), 122.7 (ArCH), 124.2 (ArC), 124.5 (ArCH), 127.9 (ArCH), 142.8 
(ArC), 167.6 (CO2Et), 174.9 (NCO); MS: m/z (EI): 219 (M+, 45 %), 146 (49), 
119 (11), 118 (100), 91 (39), 65 (14), 43 (12), 21 (24); HRMS: C12H13NO3 
requires: 219.0895, found: 219.0896. 
 
 
4.2.3.4. Synthesis of Ethyl 2-(2-bromo-1H-indol-1-yl)acetate 18490,96 
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Method 1 
 
Phosphorus oxybromide (0.60 g, 2.2 mmol, 1.2 equiv.) was added to a 
solution of ethyl 2-(2-oxoindolin-1-yl)acetate 220 (0.40 g, 1.8 mmol) in 
dichloromethane (40 cm3). The resulting mixture was stirred at reflux for 9 
days. A 2M NaHCO3 solution was added until effervescence stopped and the 
solution was extracted with dichloromethane (3 × 50 cm3). The organic layers 
were combined, washed with brine and dried with anhydrous MgSO4 before 
removing the solvent in vacuo. The resulting purple residue was purified by 
column chromatography (2% ethyl acetate/hexane) to afford the brominated 
compound 184 as a white solid (0.25 g, 89%) and starting material (0.12 g, 
30%); m.p. 61-63 ºC; νmax (film)/cm-1: 2999 (ArC-H), 1737 (C=O), 1625 
(ArC=C), 1111 (C-O), 784 (ArH), 606 (C-Br); 1H NMR (300 MHz; CDCl3; 
Me4Si): δH (ppm) = 1.23 (3H, t, J=7.2 Hz, CH3), 4.19 (2H, q, J=7.1 Hz, OCH2), 
4.87 (2H, s, NCH), 6.63 (1H, s, 3-H), 7.08-7.21 (3H, m, 3×ArH) 7.53 (1H, d, 
J=7.7 Hz, ArH); 13C NMR (75 MHz, CDCl3): δC (ppm) = 14.1 (CH3), 46.0 
(NCH), 61.7 (OCH2), 105.1 (3-C), 109.0 (ArCH), 113.4 (ArC), 120.0 (ArCH), 
120.6 (ArCH), 122.2 (ArCH), 128.1 (ArC), 136.9 (ArC), 167.9 (C=O); MS: m/z 
(EI): 281 (M+, 19 %), 213 (15), 210 (35), 208 (36), 201 (35), 143 (12), 129 
(19), 128 (10), 127 (18), 115 (66), 87 (15), 81 (41), 69 (14), 43 (21), 41 (100), 
39 (13), 29 (42), 28 (18), 27 (10); HRMS: C12H12NO279Br requires: 281.0051, 
found: 281.0052. 
 
Method 2 
 
Phosphorus oxybromide (0.19 g, 0.69 mmol, 1.5 equiv.) was added to a 
solution of ethyl 2-(2-oxoindolin-1-yl)acetate 220 (0.10 g, 0.46 mmol) in 
dichloromethane (10.0 cm3). The resulting mixture was stirred at reflux for 1 h 
and imidazole (0.04 g, 0.6 mmol, 1.2 equiv.) was added. The solution was 
stirred at reflux for a further 48 h. A 2M NaHCO3 solution was added until 
effervescence stopped and the solution was extracted with dichloromethane 
(3 × 50 cm3). The organic layers were combined, washed with brine and dried 
with anhydrous MgSO4 before removing the solvent in vacuo. The resulting 
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residue was purified by column chromatography (2% ethyl acetate/hexane) to 
afford starting material 220 (0.05 g, 40%) and uncharacterizable material. 
 
Method 3 
 
Phosphorus oxybromide (0.19 g, 0.69 mmol, 1.5 equiv.) was added to a 
solution of ethyl 2-(2-oxoindolin-1-yl)acetate 220 (0.10 g, 0.46 mmol) in 
dichloroethane (5.0 cm3). The resulting mixture was stirred at reflux for 24 h. A 
2M NaHCO3 solution was added until effervescence stopped and the solution 
was extracted with dichloromethane (3 × 50 cm3). The organic layers were 
combined, washed with brine and dried with anhydrous MgSO4 before 
removing the solvent in vacuo. The resulting purple residue was purified by 
column chromatography (2% ethyl acetate/hexane) to afford 2 
uncharacterizable compounds. 
 
Method 4 
 
Phosphorus oxybromide (0.19 g, 0.69 mmol, 1.5 equiv.) was added to a 
solution of ethyl 2-(2-oxoindolin-1-yl)acetate 220 (0.10 g, 0.46 mmol) in 
dichloroethane (5.0 cm3). The resulting mixture was stirred at reflux for 1 h 
and imidazole (0.04 g, 0.6 mmol, 1.2 equiv.) was added. The solution was 
stirred at reflux for a further 48 h. A 2M NaHCO3 solution was added until 
effervescence stopped and the solution was extracted with dichloromethane 
(3 × 50 cm3). The organic layers were combined, washed with brine and dried 
with anhydrous MgSO4 before removing the solvent in vacuo. The resulting 
residue was purified by column chromatography (2% ethyl acetate/hexane) to 
afford the brominated compound 184 as a white solid (0.04 g, 30%). 
 
Method 5 
 
Phosphorus bromide (0.05 cm3, 0.6 mmol, 1.2 eq) was added to a solution of 
ethyl 2-(2-oxoindolin-1-yl)acetate 220 (0.10 g, 0.46 mmol) in CH3CN (5.0 
cm3). The resulting mixture was stirred at reflux for 96 h. A 2M NaHCO3 
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solution was added until effervescence stopped and the solution was 
extracted with dicholoromethane (3 × 30 cm3). The organic layers were 
combined, washed with brine and dried with anhydrous MgSO4 before 
removing the solvent in vacuo. The resulting residue was purified by column 
chromatography (2% ethyl acetate/hexane) to afford starting material 220 
(0.095 g, 95%). 
 
 
4.2.3.5. Synthesis of Ethyl 2-(2-(2-formylphenyl)-1H-indol-1-yl)acetate 
18683 
 
186
1
2
34
5
6 N
7
O
O
O
 
 
Tetrakis(triphenylphosphine)palladium(0) (0.11 g, 0.089 mmol, 10 mol %) was 
added to a 50 cm3 flame dried, round bottom flask, equipped with a 
condenser and dropping funnel. The bromide 184 (0.25 g, 0.89 mmol), 2-
formylphenylboronic acid 185 (0.20 g, 1.1 mmol, 1.5 equiv.) and DME (2.6 
cm3, 1.1% of Na2CO3 solution) were combined in the dropping funnel and 
degassed before adding to the flask. An aqueous 2M Na2CO3 solution (0.47 g, 
4.45 mmol, 5 equiv.) was added to the dropping funnel, degassed and then 
added to the flask. The dropping funnel was closed and the resulting mixture 
was degassed once more before refluxing for 10 min. Water (10 cm3) was 
added and the solution was extracted with ethyl acetate (3 × 20 cm3). The 
organic layers were combined and dried with anhydrous magnesium sulfate. 
The solvent was removed in vacuo and the residue was purified by silica gel 
column chromatography (2% ethyl acetate/hexane) to afford ethyl 2-(2-(2-
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formylphenyl)-1H-indol-1-yl)acetate 186 as an orange, viscous oil (0.21 g, 
77%). Rf = 0.59 (30% ethyl acetate/hexane); νmax (film)/cm-1: 2982 (ArC-H), 
1748 and 1693 (C=O), 1600 (ArC=C), 1200 (C-O), 766 (ArH); 1H NMR (300 
MHz; CDCl3; Me4Si): δH (ppm) = 1.15 (3H, t, J=7.1 Hz, CH3), 4.10 (2H, q, 
J=7.1 Hz, OCH2) 4.71 (2H, s, NCH2), 6.63 (1H, s, 3-H), 7.18-7.33 (3H, m, 
3×ArH), 7.51 (1H, d, J=7.6 Hz, ArH), 7.59 (1H, t, J=7.4 Hz, ArH), 7.68 (2H, 
ddd, J=1.5, 4.2 and 7.4 Hz, 2×ArH), 8.08 (1H, dd, J=1.1 and 7.7 Hz, ArH), 
10.0 (1H, s, CHO); 13C NMR (75 MHz, CDCl3): δC (ppm) = 14.0 (CH3), 45.7 
(NCH2), 61.7 (OCH2), 107.1 (3-H), 109.3 (ArCH), 120.9 (ArCH), 121.0 (ArCH), 
123.0 (ArCH), 127.9 (ArC), 129.2 (ArCH), 131.5 (ArCH), 133.3 (ArCH), 135.2 
(ArC), 135.4 (ArC), 135.8 (ArC), 137.9 (ArC), 168.3 (CO2Et), 192.1 (CHO); 
MS: m/z (EI): 307 (M+, 65 %), 279 (33), 278 (39), 250 (24), 235 (13), 234 (47), 
233 (25), 220 (19), 219 (23), 210 (12), 207 (20), 206 (54), 205 (43), 204 (47), 
203 (15), 192 (13), 182 (36), 181 (100), 178 (20), 177 (14), 165 (19), 153 (31), 
152 (49), 151 (23), 150 (16), 149 (56), 136 (24), 102 (12), 86 (34), 84 (45), 77 
(19), 76 (23), 51 (10), 47 (12), 29 (12); HRMS: C19H17NO3 requires: 307.1208, 
found: 307.1200. 
 
4.2.3.6. Synthesis of Ethyl indolo[2,1-a]isoquinoline-6-carboxylate 18377 
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To a solution of ethyl 2-(2-(2-formylphenyl)-1H-indol-1-yl)acetate 186 (0.15 g, 
0.49 mmol) in DMF (15 cm3) was added tBuOK (0.006 g, 0.05 mmol, 10 mol 
%) at room temperature. The resulting mixture was stirred for 2 min. before it 
was quenched with water (25 cm3) and then extracted with ether (3 × 25 cm3). 
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The organic layers were combined, dried with MgSO4 and the solvent was 
removed in vacuo. The resulting residue was purified by column 
chromatography (2% ethyl acetate hexane) to afford ethyl indolo[2,1-
a]isoquinoline-6-carboxylate 183 (0.083 g, 59%) as a yellow-orange solid. Rf = 
0.65 (30% ethyl acetate/hexane); m.p. 109-110 ºC; νmax (film)/cm-1: 3000 
(ArC-H), 1724 (C=O), 1601 (ArC=C), 738 (ArH); 1H NMR (300 MHz; CDCl3; 
Me4Si): δH (ppm) = 1.41 (3H, t, J=7.1 Hz, CH3), 4.51 (2H, q, J=7.1 Hz, OCH2), 
7.12 (1H, s, 12-H), 7.17-7.26 (3H, m, 3×ArH), 7.36 (1H, t, J=7.4 Hz, ArH), 
7.49 (2H, dd, J=7.7 and 18.9 Hz, 2×ArH), 7.61 (1H, d, J=8.2 Hz, ArH), 7.74 
(1H, d, J=7.6 Hz, ArH), 8.07 (1H, d, J=7.9 Hz, ArH); 13C NMR (75 MHz, 
CDCl3): δC (ppm) = 14.2 (CH3), 62.2 (OCH2), 95.4 (ArCH), 113.8 (ArCH), 
115.2 (ArCH), 120.7 (ArCH), 121.0 (ArCH), 122.2 (ArCH), 123.4 (ArCH), 
126.9 (ArC), 127.3 (ArC), 127.7 (ArCH), 127.8 (ArCH), 128.8 (ArC), 129.2 
(ArC), 129.3 (ArC), 131.7 (ArC), 135.5 (ArC), 164.1 (OC=O); MS: m/z (EI): 
289 (M+, 100 %), 261 (67), 216 (19), 187 (5), 131 (7), 108 (8); HRMS: 
C19H15NO2 requires: 289.1103, found: 289.1081. 
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Appendix I – Crystal Data for 1-Benzyl-3,3-dichloroindolin-2-
one 209 
 
Empirical formula C15 H11 Cl2 N O 
Formula weight 292.15 
Temperature 293(2) K 
Wavelength 0.71073 A 
Unit cell dimensions a = 10.4847(13) A, b = 14.4641(18) A   
c = 9.2203(11) A      
α = 90°, β = 107.244(2)°, γ= 90°  
Crystal system Monoclinic 
Volume 1335.4(3) Å3
Z, Calculated density 4,  1.453 Mg/m3
Absorption coefficient 0.475 mm-1
F(000)                             600 
Theta range for data collection 2.03 to 28.28° 
Limiting indices -13<=h<=11, -19<=k<=18, -
11<=l<=12 
Reflections collected / unique 8978 / 3284 [R(int) = 0.0281] 
Completeness to theta = 28.28 99.3% 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3284 / 0 / 216 
Goodness-of-fit on F2 1.040 
Final R indices [I>2sigma(I)] R1 = 0.0321, wR2 = 0.0828 
R indices (all data) R1 = 0.0431, wR2 = 0.0878 
Largest diff. peak and hole 0.341 and -0.361 e.A^-3 
Table 1: Crystal data and structure refinement for 1-Benzyl-3,3-dichloro-
indolin-2-one 209 
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Atom x y z U(eq) 
o(1) 3766(1) 281(1) 2989(1) 44(1) 
c(1) 579(1) 1988(1) 4981(2) 32(1) 
c(2) 436(2) 2942(1) 5118(2) 35(1) 
c(3) 1279(2) 3552(1) 4691(2) 33(1) 
c(4) 2286(1) 3242(1) 4101(2) 29(1) 
c(5) 2416(1) 2295(1) 3965(1) 24(1) 
c(6) 1577(1) 1676(1) 4402(1) c25(1) 
c(7) 2017(1) 720(1) 4159(2) 28(1) 
c(8) 3161(1) 878(1) 3430(2) 29(1) 
c(9) 4395(1) 2252(1) 2903(2) 31(1) 
c(10) 5491(1) 2649(1) 4216(2) 26(1) 
c(11) 5813(2) 3582(1) 4255(2) 35(1) 
c(12) 6839(2) 3937(1) 5458(2) 43(1) 
c(13) 7547(2) 3362(1) 6610(2) 41(1) 
c(14) 7237(2) 2431(1) 6577(2) 38(1) 
c(15) 6207(1) 2076(1) 5390(2) 31(1) 
n(1) 3342(1) 1812(1) 3408(1) 26(1) 
cl(1) 2707(1) 120(1) 5914(1) 39(1) 
cl(2) 745(1) 27(1) 2934(1) 39(1) 
Table 2: Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for 1-Benzyl-3,3-dichloroindolin-2-one 209. U(eq) is 
defined as one third of the trace of the orthogonalized Uij tensor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 124
Bond Bond Length 
O(1)-c(8) 1.2103(17) 
C(1)-c(6) 1.3838(19) 
C(1)-c(2) 1.398(2) 
C(1)-h(1) 0.983(17) 
C(2)-c(3) 1.386(2) 
C(2)-h(2) 0.931(19) 
C(3)-c(4) 1.397(2) 
C(3)-h(3) 1.013(17) 
C(4)-c(5) 1.3853(19) 
C(4)-h(4) 0.932(16) 
C(5)-c(6) 1.3966(18) 
C(5)-n(1) 1.4110(17) 
C(6)-c(7) 1.4947(19) 
C(7)-c(8) 1.5560(19) 
C(7)-cl(2) 1.7807(13) 
C(7)-cl(1) 1.7887(14) 
C(8)-n(1) 1.3644(18) 
C(9)-n(1) 1.4651(17) 
c(9)-c(10) 1.5133(19) 
c(9)-h(9a) 0.959(17) 
c(9)-h(9b) 0.980(17) 
c(10)-c(11) 1.388(2) 
c(10)-c(15) 1.393(2) 
c(11)-c(12) 1.394(2) 
c(11)-h(11) 0.917(18) 
c(12)-c(13) 1.379(3) 
c(12)-h(12) 0.94(2) 
c(13)-c(14) 1.384(2) 
c(13)-h(13) 0.97(2) 
c(14)-c(15) 1.388(2) 
c(14)-h(14) 0.945(19) 
c(15)-h(15) 0.943(17) 
Table 3:  Bond lengths [A] for 1-Benzyl-3,3-dichloroindolin-2-one 209 
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Bond Bond Angle 
c(6)-c(1)-c(2) 118.05(13) 
c(6)-c(1)-h(1) 120.4(10) 
c(2)-c(1)-h(1) 121.5(10) 
c(3)-c(2)-c(1) 120.58(14) 
c(3)-c(2)-h(2) 117.7(12) 
c(1)-c(2)-h(2) 121.7(12) 
c(2)-c(3)-c(4) 121.69(14) 
c(2)-c(3)-h(3) 116.7(9) 
c(4)-c(3)-h(3) 121.5(9) 
c(5)-c(4)-c(3) 117.31(13) 
c(5)-c(4)-h(4) 122.1(10) 
c(3)-c(4)-h(4) 120.6(10) 
c(4)-c(5)-c(6) 121.38(12) 
c(4)-c(5)-n(1) 128.31(12) 
c(6)-c(5)-n(1) 110.31(11) 
c(1)-c(6)-c(5) 121.00(13) 
c(1)-c(6)-c(7) 131.46(13) 
c(5)-c(6)-c(7) 107.51(11) 
c(6)-c(7)-c(8) 103.96(11) 
c(6)-c(7)-cl(2) 114.14(9) 
c(8)-c(7)-cl(2) 109.69(9) 
c(6)-c(7)-cl(1) 111.92(9) 
c(8)-c(7)-cl(1) 107.77(9) 
cl(2)-c(7)-cl(1) 109.06(7) 
o(1)-c(8)-n(1) 127.77(13) 
o(1)-c(8)-c(7) 125.99(13) 
n(1)-c(8)-c(7) 106.23(11) 
n(1)-c(9)-c(10) 112.07(11) 
n(1)-c(9)-h(9a) 106.1(10) 
c(10)-c(9)-h(9a) 110.9(10) 
n(1)-c(9)-h(9b) 108.1(10) 
c(10)-c(9)-h(9b) 110.8(10) 
h(9a)-c(9)-h(9b) 108.8(13) 
c(11)-c(10)-c(15) 119.15(13) 
c(11)-c(10)-c(9) 120.73(13) 
c(15)-c(10)-c(9) 120.11(13) 
c(10)-c(11)-c(12) 120.18(15) 
c(10)-c(11)-h(11) 119.1(11) 
c(12)-c(11)-h(11) 120.7(11) 
c(13)-c(12)-c(11) 120.21(15) 
c(13)-c(12)-h(12) 121.6(12) 
c(11)-c(12)-h(12) 118.1(12) 
Table 4 
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Bond Bond Angle 
c(12)-c(13)-c(14) 120.01(15) 
c(12)-c(13)-h(13) 120.3(11) 
c(14)-c(13)-h(13) 119.7(11) 
c(13)-c(14)-c(15) 120.02(15) 
c(13)-c(14)-h(14) 122.5(11) 
c(15)-c(14)-h(14) 117.5(11) 
c(14)-c(15)-c(10) 120.43(14) 
c(14)-c(15)-h(15) 121.6(10) 
c(10)-c(15)-h(15) 118.0(10) 
c(8)-n(1)-c(5) 111.83(11) 
c(8)-n(1)-c(9) 123.75(12) 
c(5)-n(1)-c(9) 124.40(11) 
Table 4 Continued: Bond angles [degrees] for 1-Benzyl-3,3-dichloroindolin-2-
one 209 
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Bond Bond Angle 
c(6)-c(1)-c(2)-c(3) -0.3(2) 
c(1)-c(2)-c(3)-c(4) 0.6(2) 
c(2)-c(3)-c(4)-c(5) -0.3(2) 
c(3)-c(4)-c(5)-c(6) -0.10(19) 
c(3)-c(4)-c(5)-n(1) 179.95(12) 
c(2)-c(1)-c(6)-c(5) -0.1(2) 
c(2)-c(1)-c(6)-c(7) 177.75(14) 
c(4)-c(5)-c(6)-c(1) 0.29(19) 
n(1)-c(5)-c(6)-c(1) -179.75(12) 
c(4)-c(5)-c(6)-c(7) -177.99(12) 
n(1)-c(5)-c(6)-c(7) 1.97(14) 
c(1)-c(6)-c(7)-c(8) 178.48(14) 
c(5)-c(6)-c(7)-c(8) -3.49(13) 
c(1)-c(6)-c(7)-cl(2) 59.00(18) 
c(5)-c(6)-c(7)-cl(2) -122.96(10) 
c(1)-c(6)-c(7)-cl(1) -65.48(17) 
c(5)-c(6)-c(7)-cl(1) 112.56(10) 
c(6)-c(7)-c(8)-o(1) -176.75(14) 
cl(2)-c(7)-c(8)-o(1) -54.30(18) 
cl(1)-c(7)-c(8)-o(1) 64.32(16) 
c(6)-c(7)-c(8)-n(1) 3.86(14) 
cl(2)-c(7)-c(8)-n(1) 126.32(10) 
cl(1)-c(7)-c(8)-n(1) -115.06(10) 
n(1)-c(9)-c(10)-c(11) -122.02(14) 
n(1)-c(9)-c(10)-c(15) 59.21(17) 
c(15)-c(10)-c(11)-c(12) -0.2(2) 
c(9)-c(10)-c(11)-c(12) -178.95(13) 
c(10)-c(11)-c(12)-c(13) 0.6(2) 
c(11)-c(12)-c(13)-c(14) -0.3(2) 
c(12)-c(13)-c(14)-c(15) -0.4(2) 
c(13)-c(14)-c(15)-c(10) 0.8(2) 
c(11)-c(10)-c(15)-c(14) -0.5(2) 
c(9)-c(10)-c(15)-c(14) 178.28(13) 
o(1)-c(8)-n(1)-c(5) 177.75(14) 
c(7)-c(8)-n(1)-c(5) -2.88(14) 
o(1)-c(8)-n(1)-c(9) -3.7(2) 
c(7)-c(8)-n(1)-c(9) 175.62(11) 
c(4)-c(5)-n(1)-c(8) -179.37(13) 
c(6)-c(5)-n(1)-c(8) 0.67(15) 
c(4)-c(5)-n(1)-c(9) 2.1(2) 
c(6)-c(5)-n(1)-c(9) -177.82(12) 
c(10)-c(9)-n(1)-c(8) -107.47(15) 
c(10)-c(9)-n(1)-c(5) 70.85(17) 
Table 5: Torsion angles [degrees] for 1-Benzyl-3,3-dichloroindolin-2-one 209 
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Appendix II – Selected NMR Spectra 
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